太平洋 – ワールドソルーションズLLC

U.S.A. アメリカ Vol.116（California カリフォルニア州 Vol.2: pharmaceutical corporations 製薬会社）

All the below link and tweets are in English.

取り急ぎ以下貼っておきます。

California Vol.25 (corporations: Amgen)

ツイッター検索で上記製薬会社名及び Japan や日本の5製薬会社各社名を入れて出て来たもの

Since 2011, Amgen has doubled its global presence and, with the addition of Amgen K.K., that now includes Japan. In 2019 alone, we invested more than $4 billion in global research & development to serve more patients. Press release: https://t.co/uBT5FT4fnw 2/2 pic.twitter.com/wstcLnvnnz

— Amgen (@Amgen) April 1, 2020

We’re pleased to introduce Amgen K.K., a wholly-owned affiliate in Japan which will enable Amgen to build a strong presence in the country moving forward. Amgen K.K. will focus on bringing our full global pipeline to Japanese patients. Press release: https://t.co/uBT5FT4fnw 1/2 pic.twitter.com/fkqXj6g6Tm

— Amgen (@Amgen) April 1, 2020

#Amgen’s New #Osteoporosis Treatment Receives First Worldwide Approval in Japan https://t.co/JooD4GUxgK @UCB_News

— Amgen (@Amgen) January 8, 2019

#ICYMI, #Amgen’s medicine for R/R ALL has received marketing authorization in Japan. Learn more: https://t.co/UMrQByPqtD

— Amgen (@Amgen) September 26, 2018

#Amgen receives approval for our R/R ALL medicine in Japan. Learn more: https://t.co/UMrQByPqtD

— Amgen (@Amgen) September 25, 2018

Applications for the #AmgenScholars Program in Europe, Japan & the U.S. are open now: https://t.co/uVtH11AW1w pic.twitter.com/rt3JekGqix

— Amgen (@Amgen) December 13, 2017

The #AmgenScholars Japan Symposium was a global gathering of passionate young #scientists. Learn more: https://t.co/CvuLhtGpQF

— Amgen (@Amgen) January 10, 2017

#Amgen & @UCB_news announce submission of marketing application in Japan for osteoporosis treatment https://t.co/Z27LnrD17x

— Amgen (@Amgen) December 20, 2016

#Amgen submits marketing application in Japan http://t.co/DSa8puB2Ms

— Amgen (@Amgen) March 20, 2015

#Amgen presents new detailed cholesterol data from Japan study at #ACC15 http://t.co/A8Crv951Em

— Amgen (@Amgen) March 14, 2015

Japan’s #biosimilar guidelines aim toward #quality, #safety and #efficacy. Full article: http://t.co/xzDMFOgozN via @GaBIOnline_

— Amgen (@Amgen) September 27, 2013

As the Japan #AmgenScholars Program enters its fifth year, Steve Sugino, Vice President of @Amgen, caught up with its Directors, Dr. Ichiro Sakuma and Dr. Fuyuki Ishikawa about their experience with the program. https://t.co/2opFJZxRUb

— Amgen Foundation (@AmgenFoundation) April 10, 2019

@Amgen establishes a wholly-owned affiliate in Japan by announcing the completion of 49% share buyout in a 7-year-old joint venture with Astellas Pharma Inc.#Japan #Healthcare #GeneOnline https://t.co/rfMMQHKd9e

— GeneOnline (@GeneOnlineNews) April 1, 2020

#Pharma with '#AI friendly' executives will prosper: US, Germany, and Japan-based companies lead the pack, says @DK_Analytics report // @DeepTech_VC

Read: https://t.co/Ra1FDwHAXE @Boehringer @GSK @LillyPad @Evotec @pfizer @Amgen @BayerPharma @Roche @Novartis @bmsnews @Merck pic.twitter.com/df32pzpwpr

— Outsourcing-Pharma (@OutsourcPharma) July 8, 2019

What are the key challenges for #osteoporosis patients in #Japan and how are these affecting their daily lives? Our persona portrait explores the issue. #bonehealthAsia https://t.co/6I7R6gsnr3 (Commissioned By @Amgen) pic.twitter.com/XSzyeHQBpH

— The Economist Intelligence Unit (@TheEIU) March 28, 2019

In Japan, #cardiovascular diseases (CVDs) levy US$24.3bn in direct and indirect costs on individuals, their households and the public finances. What can be done to reduce CVDs costs? Download report> https://t.co/GvIrb2yynd (Via @Amgen) #HearthealthAsia pic.twitter.com/b0syBOLu9W

— The Economist Intelligence Unit (@TheEIU) December 21, 2018

Amgen and UCB's Evenity approved in Japan for #osteoporosis https://t.co/GvzSmOIQv5 #pharma @Amgen @ucb_news pic.twitter.com/gcs0QJ4SJi

— Pharmafocus (@Pharmafocus) January 9, 2019

BLINCYTO® (Blinatumomab) Approved in Japan for the Treatment of Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia @Amgen https://t.co/TxsNrf7oZ1

— Hematopoiesis News (@Hema_News) September 28, 2018

Japan to cut drug prices, @bmsinfo @OnoPharmaOpdivo (nivolumab) & @Amgen Repatha (evolocumab) into the spotlight https://t.co/3xzxFn3muY

— ilS (@ilsintelligence) September 19, 2016

@Amgen's #Repatha wins first PCSK9 OK in #Japan https://t.co/EeEEqDTq40 @FiercePharma #hypercholesterolemia #cholesterol #cardiovascular

— Plexus Ventures (@PlexusVentures) January 25, 2016

@Amgen signs autoimmune pact with Japan's Teijin – Read more via @PharmaTimes here: http://t.co/OlktgphSz9 #autoimmune #Japan #pharma

— Plexus Ventures (@PlexusVentures) August 1, 2013

#Amgen announces approval of Repatha® (evolocumab) in Japan https://t.co/uOn5L1sab3

— Amgen (@Amgen) January 22, 2016

#Amgen and Astellas Announce Japan Alliance http://t.co/oRgJwzycLz

— Amgen (@Amgen) May 29, 2013

Amgen Repurchases Astellas’ Stakes in Amgen Astellas JV to Strengthen its Footprints in Japan @Amgen @AstellasUS https://t.co/9RLS4NdZg2 pic.twitter.com/5eHR6tMorO

— PharmaShots – Incisive news in 3 shots (@Pharmashot) April 1, 2020

@Amgen establishes a wholly-owned affiliate in Japan by announcing the completion of 49% share buyout in a 7-year-old joint venture with Astellas Pharma Inc.#Japan #Healthcare #GeneOnline https://t.co/rfMMQHKd9e

— GeneOnline (@GeneOnlineNews) April 1, 2020

Amgen & Astellas Enter Into Japan Alliance http://t.co/345v46RfBp @amgen @AstellasUS

— Asian Scientist Magazine (@asianscientist) June 7, 2013

#Amgen and @DaiichiSankyoJP announce agreement to commercialize #biosimilars in Japan. https://t.co/bVDl6FJaet

— Amgen (@Amgen) July 14, 2016

#collaboration between @Amgen and @EUdaiichisankyo to #commercialize nine #biosimilars in #Japan.
For more: https://t.co/R2fyWqM00i

— Roots Analysis (@RootsAnalysis) July 18, 2016

@Amgen & @DaiichiSankyo announce agreement to commercialize #biosimilars in #Japan https://t.co/D3xmqmRiJo @WorldPharmaNews #biosim #pharma

— Plexus Ventures (@PlexusVentures) July 14, 2016

.@Amgen agrees deal to commercialise biosimilars in Japan with @EUdaiichisankyo https://t.co/O7cdaYN3Ml

— Pharmafocus (@Pharmafocus) July 14, 2016

Amgen And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan https://t.co/KsanOqAcmi [h/t @Amgen]

— Endpoints News (@endpts) July 14, 2016

.@Amgen partners with @DaiichiSankyoJP to market biosimilars in Japan https://t.co/fieuGDAidm via @biopharmadive pic.twitter.com/hsWno7fsfd

— NewYork Pharma Forum (@NYPharmaForum) July 23, 2016

.@Amgen partners with @DaiichiSankyoJP to market biosimilars in Japan https://t.co/UpKRfQvYGV via @biopharmadive pic.twitter.com/6H9mg6Ou5y

— NewYork Pharma Forum (@NYPharmaForum) July 22, 2016

AbbVie, Amgen and Takeda test anti-inflammatory drugs in joint COVID-19 study | @AbbVieUS @Amgen @TakedaOncology @WHO #cambridge #massachusetts #thousandoaks #california #covid19 #biotech https://t.co/HAJfTVcTOR

— Pharm2Market (@pharm2market) August 6, 2020

Rival drugmakers launch joint trial of drugs for #COVID19 https://t.co/LcRNln9jaK @gulf_news #coronavirus @AbbVie @Amgen @Takeda

— Gulf News Business (@GulfNewsBiz) August 3, 2020

Our heads of R&D, Takeda's Andy Plump and @Amgen's David Reese, published a @statnews opinion article about the efforts of the COVID R&D Alliance and the power of adaptive trials. Learn how a global network can accelerate the fight against #COVID19 https://t.co/x5gYQT8nVj pic.twitter.com/lXs0YOkkVK

— Takeda (@TakedaPharma) July 23, 2020

Affymax banks $50M milestone on ESA drug approval http://t.co/T5PeWE5y $AFFY $AMGN @Takeda @Amgen

— FierceBiotech (@FierceBiotech) April 10, 2012

#Peptide_Based_Cancer_Therapeutics Market Size Worth $17.18 Billion By 2027

Read More : https://t.co/k5GadYh4D3

major market participants :@AstraZeneca @Allergan @Pfizer @Takeda @Amgen,@JNJNews #peptidetherapeutics #healthcare pic.twitter.com/8LF46fwnPm

— karishma mulani (@karishmamulani5) July 28, 2020

.@TakedaPharma to return molecules/ products for Japan to @Amgen https://t.co/14hGlLgKu6

— Pharmafocus (@Pharmafocus) June 27, 2016

参考．上記linkに無いもの

“The world now recognizes that we need innovation to get out from under the crush of this pandemic.”

Amgen CEO Bob Bradway spoke with @FT's @HannahKuchler about navigating #COVID19 now and preparing for a post-COVID world. #FTUSPharma $AMGN

— Amgen (@Amgen) October 6, 2020

If you’re a provider, visit our updated #COVID19 & cardiovascular resource page which also includes a link to important resources in the @HFSA COVID-19 resource hub to learn more.

Details in the link below.

— Amgen (@Amgen) October 1, 2020

Amgen's Michelle Carillo from our advocacy relations team will join for this discussion. Registration details in link below. #COVID19 https://t.co/wLqtf8dr8A

— Amgen (@Amgen) September 29, 2020

Moderated by MassBio CEO @BobCoughlin, Michelle Carrillo @Amgen, Dr. Meghan Mooradian @MassGeneralNews & Kirsten Sloan @ACSCAN join us now for a discussion on how #COVID19 has impacted cancer care & the path to diagnosis & treatment. Thank you, @Amgen for sponsoring this event! pic.twitter.com/mG5Lb9Hd8f

— MassBio (@MassBio) October 1, 2020

Dr. Steven Galson of @Amgen discussing #COVID19 and the promise of genetic sequencing. A great conversation on how science is meeting this critical moment for our world. #CALeg pic.twitter.com/rn7kDoqWap

— California Biotech (@CABiotech) May 28, 2020

.@PhRMA companies and CMTA members @LillyPad, @TakedaPharma, @pfizer, @JNJInnovation, @Amgen, @Novartis part of coordinated intl. research response for #COVID19 treatments and vaccines. #MakingCA #ProtectingUS https://t.co/K81hC2aHPe

— California Manufacturers & Technology Assn. (@cmta) April 21, 2020

Wonderful news from CLSA members @Amgen and @LillyPad!

The spirit of life sciences collaboration embodies our ability to defeat this pandemic! #innovation > #COVID19 https://t.co/NnfbMCq62H

— California Life Sciences Association (CLSA) (@CALifeSciences) September 17, 2020

In the fight against the pandemic, @LillyPad announced a partnership with @Amgen to #manufacture a new #COVID19 treatment! #CreatorsRespond https://t.co/ihMQVEWabZ

— Friends of Manufacturing (@FriendsofMFG) September 17, 2020

Lilly and Amgen announce manufacturing collaboration for COVID-19 antibody therapies. @WorldPharmaNews @LillyPad @Amgen #COVID19 #antibodies #LYCoV555 #lifesciences #pharma https://t.co/h2TiFilMDl pic.twitter.com/bUbAsek5xs

— Greybridge (@GreybridgeRoles) September 22, 2020

With rising numbers of #diabetic and #chronicdisease #patients, the #wearable #injectors market is growing for ease of #drugadministration. (https://t.co/dNV34tAMEh)
.
.
.#injection #syringe #drugdelivery #medicine #Amgen #BD #Insulet #Medtronic #COVID19 #TBRC #GlobalMarketModel pic.twitter.com/jExYhkjBf7

— TBRC (@tbrc_info) September 22, 2020

Amgen adapts to pandemic with #Prolia home infusion; #Otezla as COVID-19 therapy @Amgen #covid19 #earnings @MichaelHGibney reports https://t.co/lsTmjgdaDz pic.twitter.com/psknF2KIok

— Market Intelligence: Healthcare (@SPGMIHealthcare) July 29, 2020

Discover what it's like to be an outbreak response team member in Amgen #BiotechExperience's new virtual curriculum module that explores the #COVID19 pandemic, Responding to a Mystery Illness.
Read all about it: https://t.co/kecQFvdMA4 pic.twitter.com/TqquQDmqdT

— ABE Program Office (@ABEProgOffice) April 27, 2020

Working with @AdaptiveBiotech, @Amgen is working on a drug to treat #COVID19. #CreatorsRespond https://t.co/BKYN0PgIk6

— The NAM (@ShopFloorNAM) April 3, 2020

First Patients Registered in I-SPY COVID Trial https://t.co/4wzf17dWb6 via @GMP news #AbbVie #Amgen #ClinicalTrials #Covid19 #Takeda #GMPNews

— GMPnews.Net (@GMPnewsNet) August 4, 2020

Tune in as @American_Heart CEO @NancyatHeart and @Amgen CEO Bob Bradway discuss #COVID19 rapid response efforts, especially for heart disease and stroke patients who are at higher risk & rightfully concerned. https://t.co/rAOt9UJFD4

— American Heart News (@HeartNews) May 19, 2020

Thank you @Amgen Canada for your donations, supplies, and expertise to our Canadian communities to help fight against #COVID19. #CanadaResilient Learn more > https://t.co/70V9BlXh29 pic.twitter.com/Mo34pp6FPg

— Mississauga Business (@MississaugaEDO) May 6, 2020

At shareholder meetings this spring investors asked #BigPharma to commit to freeze prices on key drugs in light of the #COVID19 pandemic. Tomorrow the industry is set to again raise prices. CEO Bradway of @Amgen – will you commit? https://t.co/Aratl9g4iU

— ICCR (@ICCRonline) June 30, 2020

#NasdaqListed @Amgen marks a major milestone with a note of gratitude to #healthcare workers.

How they're stepping up to address the #COVID19 pandemic: https://t.co/PBb1vBMhAd https://t.co/0pWytEJcHp pic.twitter.com/R9aolBQRET

— Nasdaq (@Nasdaq) April 8, 2020

Boehringer Ingelheim-backed COVID researchers identify new antibodies to fight the virus | @boehringerus @UniCologneNY @DZIF_ @lillypad @Regeneron @Amgen @AstraZeneca #immunesystem #covid19 #biotech #research https://t.co/T8Y9zaIVX0

— Pharm2Market (@pharm2market) July 11, 2020

U.S.A. アメリカ Vol.114（New Jersey ニュージャージー州 Vol.2: pharmaceutical corporations 製薬会社）

All the below links and tweets are in English.

取り急ぎ以下貼っておきます。

New Jersey Vol.9 (corporations: Johnson & Johnson)
today

Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant https://t.co/fFsmSQ7v9H

— CNBC (@CNBC) October 13, 2020

ツイッター検索で上記製薬会社及び Japan や日本の5製薬会社各社名を入れて出て来たもの

We're proud to share this powerful #NationalNursesWeek story. Learn how the 2011 earthquake & tsunami in Japan inspired the Tomodachi #JNJ Disaster Nursing Training Program, and meet the survivors-turned-nursing students rebuilding their communities: https://t.co/prdG4fDmBa pic.twitter.com/MQOgQDm8y8

— Johnson & Johnson (@JNJNews) May 8, 2019

In the aftermath of 2011’s Great East Japan Earthquake, #JNJ has partnered with @USJC to support reconstruction efforts. Learn how the program trains student #nurses to become frontline healthcare workers who help keep their communities safe: https://t.co/GkRRjKZ7vP #IDDR2018 pic.twitter.com/Jjs4D964Hk

— Johnson & Johnson (@JNJNews) October 15, 2018

#JNJ Chairman & CEO Alex Gorsky had breakfast w/industry leaders and Prime Minister Shinzo Abe of Japan to discuss #healthcare #innovation pic.twitter.com/AjwL4lminc

— Johnson & Johnson (@JNJNews) February 10, 2017

During a visit to Japan this week, Sandi Peterson spoke at the 12th annual Healthy Society Award Ceremony in Tokyo. pic.twitter.com/MtdXwN3JcR

— Johnson & Johnson (@JNJNews) April 1, 2016

ICYMI: #JNJ CEO Alex Gorsky spoke w/@WSJ about emerging innovation opportunities in Japan: http://t.co/DpQfhwBYJo pic.twitter.com/krG953vH6x

— Johnson & Johnson (@JNJNews) May 1, 2015

"I believe the most exciting new frontier in health care is wellness."-#JNJ CEO Alex Gorsky at U.S.-Japan seminar pic.twitter.com/HiRqjmOXEI

— Johnson & Johnson (@JNJNews) May 1, 2015

#JNJ CEO Alex Gorsky & Prime Minister @AbeShinzo discuss business & innovation at U.S.-Japan investment seminar. pic.twitter.com/b9J0IbPBiQ

— Johnson & Johnson (@JNJNews) May 1, 2015

#JNJ is the fastest growing top-10 global pharmaceutical company in the US, Europe and Japan – Duato

— Johnson & Johnson (@JNJNews) July 15, 2014

Congrats to the Japan-based awardees of the #WorldWithoutDisease Call4Proposal! We’re proud to work alongside today’s talented innovators to develop tmw’s game-changing healthcare solutions. Read more about these research projects here https://t.co/lO4pGWniPb pic.twitter.com/9LFY9Xa3Fr

— Johnson & Johnson Innovation (@JNJInnovation) August 28, 2020

We recognize that the daily operations of researchers and companies have been impacted by the ongoing COVID-19 pandemic. With that in mind, we have postponed the deadline for applications to the Japan-based #WorldWithoutDisease Call for Proposals to May 15 https://t.co/9GQf9pDJWo pic.twitter.com/GcUim2XxQn

— Johnson & Johnson Innovation (@JNJInnovation) April 9, 2020

Though we are seeking #innovation from within #Japan, our hope is that your early-stage #research will have the potential to reach millions of patients beyond Japan. Apply to the #WorldWithoutDisease Call for Proposals here https://t.co/4GSKAJYfSz pic.twitter.com/ECktNLknBj

— Johnson & Johnson Innovation (@JNJInnovation) March 30, 2020

With @JanssenGlobal, #TakedaPharmaceutical & #ShonanHealthInnovationPark, we launched the #WorldWithoutDisease Call for Proposals in Japan. Submit your science or technology by April 15, 2020! https://t.co/4GSKAJYfSz pic.twitter.com/eIJZPbN28k

— Johnson & Johnson Innovation (@JNJInnovation) March 30, 2020

Many congratulations to #championsofscience Dr. James Allison and Dr. Tasuku Honjo of Japan on receiving the 2018 #NobelPrize. https://t.co/T8NuUFUcp5

— Johnson & Johnson Innovation (@JNJInnovation) October 1, 2018

Today, we’re proud to announce a Memorandum of Understanding for research collaborations with @univkyoto, marking #JNJInnovation’s 3rd collaboration with academia in Japan @KyotoU_News @JanssenAP #JJIAP pic.twitter.com/3an6wy4Y4u

— Johnson & Johnson Innovation (@JNJInnovation) July 2, 2018

We look forward to building relationships with the academics, entrepreneurs and scientists at the University of Tokyo that can help accelerate ideas to better answer patients’ needs in Japan and beyond @UTokyo_News_en @JanssenAP @JanssenGlobal pic.twitter.com/61QF16mHfY

— Johnson & Johnson Innovation (@JNJInnovation) February 28, 2018

Today’s MoU ceremony with the University of Tokyo marks a long-lasting collaboration as part of our ongoing commitment to nurture the healthcare ecosystem & positively impact human health through innovation in Japan and around the world @UTokyo_News_en @JanssenAP @JanssenGlobal pic.twitter.com/wU7MO2Ag6g

— Johnson & Johnson Innovation (@JNJInnovation) February 28, 2018

We are in Tokyo, Japan with #JNJ’s Chief Scientific Officer Paul Stoffels and the University of Tokyo to announce a memorandum of understanding to work together in supporting Japan’s healthcare innovation ecosystem @UTokyo_News_en @JanssenAP @JanssenGlobal @JNJCares @JNJNews pic.twitter.com/uEhjDtruDw

— Johnson & Johnson Innovation (@JNJInnovation) February 28, 2018

Great crowd at the @BioJapanExpo as our Head of #APAC Innovation Center Dong Wu presents on #JJI's work w/ academia in Japan! pic.twitter.com/6nuiVZYMSN

— Johnson & Johnson Innovation (@JNJInnovation) October 12, 2017

Our own #JanssenBD Japan lead Rami Suzuki presents JJI's strategy for collaboration alongside valued partners @BioJapanExpo @JanssenAP pic.twitter.com/aiHSdyBIT9

— Johnson & Johnson Innovation (@JNJInnovation) October 12, 2017

Winner of Dr. Paul Janssen Award announced – Dr.Yoshinori Ohsumi of Japan! #BIO2016 pic.twitter.com/MlsOHIEGlB

— Johnson & Johnson Innovation (@JNJInnovation) June 8, 2016

Next week: Where is the coronavirus vaccine search at, and what will healthcare look like in the U.S. and Japan? Join a free webinar on 8/4 with experts William Hait of @JNJInnovation, Hardy Kagimoto of @HealiosJapan and Jeanette Takamura of @ColumbiaSSW.https://t.co/7Iab7gT7ce

— U.S.-Japan Council (@USJC) July 27, 2020

.@USAsiaPacific congratulates the participants of the 5th @USJC @TOMODACHI Johnson & Johnson Disaster Nursing Training Program from #Japan. Their hands-on training and new networks gives them the skills to face future medical challenges. pic.twitter.com/MGtJnbM7ng

— EAP Bureau (@USAsiaPacific) August 16, 2019

Jun Kusunoki, @JNJInnovation’s Director of New Ventures Japan, shares some perspective on how to bridge the gap between early-stage research and commercialization of #healthcare solutions at the Japan Healthcare Venture Summit @BioJapanExpo #ChampionsOfScience pic.twitter.com/Xr7W0mRu06

— Jenny (@jennyoan) October 11, 2018

https://twitter.com/JanssenAP/status/1177073498864279552

Do you know @JNJNews ranked 1st in the Nikkei Woman gender diversity ranking in Japan? Ai Hua and our D&I champions had a great discussion on ways to improve the working environment for women pic.twitter.com/1CLOelg79N

— Janssen Asia Pacific (@JanssenAP) August 2, 2018

Johnson & Johnson in talks with Japan for COVID-19 vaccine deals.https://t.co/xkLJXeMdwv

— Nikkei Asia (@NikkeiAsia) July 17, 2020

Japan's government in talks with Johnson & Johnson to secure COVID-19 vaccine https://t.co/2iaNwIAtNZ

— The Japan Times (@japantimes) July 17, 2020

#BREAKING: Johnson & Johnson is in talks with the government of Japan and the Bill and Melinda Gates Foundation about locking up allocations of its potential #COVID-19 vaccine.@JNJGlobalHealth @gatesfoundation @AbeShinzo https://t.co/UhTEPMxsmB pic.twitter.com/Fni1EGDwYI

— Arab News Japan (@ArabNewsjp) July 16, 2020

New post: Johnson & Johnson in talks with Japan and the Gates Foundation about COVID-19 vaccine. https://t.co/h0hkrPUPct

— BiopharmaMASH (@bio_mash) July 20, 2020

Johnson & Johnson in COVID-19 vaccine deal with Gates Foundation, Japan: Johnson & Johnson… https://t.co/Xzx9ZGOEMR

— Samuel Odusami (@samuelodusami) July 16, 2020

#DRG epidemiology report estimates more than 2 million people living with #HIV across the United States, Western Europe and Japan. Detailed global report live now https://t.co/r92nrjx1mO @DRGinsights @JanssenAP @JNJNews https://t.co/Lw6etS8VQZ

— DRG Epidemiology (@DRG_Epi) August 17, 2018

Genmab Announces Approval of Darzalex® (daratumumab) in Frontline Multiple Myeloma in Japan https://t.co/q79WnxG7XT @Genmab @JNJNews @JanssenUS More Nordic life science business news at [LSS] at https://t.co/Y4sTWJwwTU pic.twitter.com/0mxJCMLbpY

— [iito] Life Science (@iitoLifeScience) August 22, 2019

WATCH: Johnson & Johnson offers $2 billion to buy Japan's Ci:z https://t.co/97P38qNx9W pic.twitter.com/rR07oOUCwW

— Reuters Business (@ReutersBiz) October 24, 2018

Johnson & Johnson offers $2 billion to buy Japan's Ci:z https://t.co/97P38qNx9W pic.twitter.com/Sw01MF7T48

— Reuters Business (@ReutersBiz) October 23, 2018

Johnson & Johnson makes $2.1 billion offer to buy out Japan cosmetics firm Ci:z https://t.co/JnlBg7uDcF

— Reuters Business (@ReutersBiz) October 23, 2018

Johnson & Johnson offers to buy remainder of Japan’s Ci:z https://t.co/6Uu3SsdH4t

— Financial Times (@FT) October 23, 2018

Johnson & Johnson offers to buy out Japan cosmetics firm Ci:z for $2.1-billion https://t.co/1HaDvBLHrK @GlobeBusiness pic.twitter.com/03HW7V1LKS

— The Globe and Mail (@globeandmail) October 23, 2018

U.S. giant Johnson & Johnson makes $2.1 billion offer to buy out Japan cosmetics firm Ci:z https://t.co/xSB6DakDPj

— The Japan Times (@japantimes) October 24, 2018

(Japan Times) U.S. giant #Johnson & #Johnson makes $2.1 billion offer to buy out #Japan cosmetics firm Ci:z : U.S. health care conglomerate Johnson & Johnson said on Tuesday it will buy all outstanding shares of Japanese skin .. https://t.co/TvWVEriwG0 pic.twitter.com/PppIwklzOS

— StoriesFlow.com (@storiesflowcom) October 24, 2018

An example of #global #brand value creation – as Johnson & Johnson offers to buy out Japan cosmetics firm Ci:z for $2.1-billion. https://t.co/2ziWnRAaQt

— Harvest Portfolios Group (@harvestetfs) October 24, 2018

.@JNJNews in talks with Japan, @gatesfoundation to lock in deals on #COVID19 #vaccine https://t.co/OBDo2FonBJ | #pharma #pharmanews #IndiaIncfightsCovid19

— ExpPharma (@ExpPharma) July 17, 2020

The Tomodachi J&J Disaster Nursing Training Program video by @JNJNews is a #SharecareAwards finalist. Created after the Great East Japan Earthquake & Tsunami, the program provides local nursing students leadership skills & disaster relief training: https://t.co/7wDnNQ7e9x pic.twitter.com/RULsOhIeHU

— Sharecare (@SharecareInc) March 6, 2019

Performance of top-20 pharma companies in 2018 https://t.co/sNusoivrtG @abbvie @Bayer @bmsnews @Celgene #Europe #Japan @JNJNews #pharma @Roche @TakedaPharma #USA

— The Pharma Letter (@ThePharmaLetter) August 27, 2019

New Darzalex approval in Japan https://t.co/bsw32vnzMS @Genmab @JanssenGlobal @JNJNews #biotech

— The Pharma Letter (@ThePharmaLetter) August 22, 2019

Up to six new HBV drugs set to launch by 2027 https://t.co/x5prE6B3EY #antivirals #china #europe @GileadSciences @ionispharma #Japan @JNJNews #pharma #research #USA

— The Pharma Letter (@ThePharmaLetter) May 30, 2019

Discuss #biocompatibility evaluation of #meddevs for #global registrations – #Europe #US #Japan #China @JNJNews https://t.co/Gb4khetgCX

— MedTech (@MedTechIC) October 31, 2016

…@jindo as part of a panel discussion with @JNJNews @alantennenberg @merckgroup @MENTOR_Hq and GHIT from Japan on communication challenges in global health chaired by @AJack of @ft_health https://t.co/kyCpWn8psb

— ISNTD (@ISNTD_Press) May 16, 2018

Our last panel discussion is all about increasing the number of women in #leadership positions with speakers such as Mayor of Providencia, Chile, Mayor of Yokohama, Japan, @JNJNews and women's entrepreneurs network! #APECChile2019 pic.twitter.com/IiWTW0PWja

— APEC Secretariat (@APEC) October 3, 2019

With every photo, #JNJ will donate $1 to moms and children in #VietNam. If you live in the US, Canada, the UK, and Japan or have any friends or relatives there, please share this information with them: https://t.co/vjnvj89WSi @donateaphoto @JNJCares @JNJNews #EveryPhotoMatters pic.twitter.com/GvenuowIrO

— UNICEF Viet Nam (@UNICEF_vietnam) December 6, 2018

Johnson & Johnson set to take full control of Japan's Ci:z. Read the News story on the OTCToolbox website. https://t.co/Zq8QHRE6hd @JNJNews

— OTCToolbox (@OTCToolbox) October 24, 2018

#ConferenceSeries #SurgicalNursing2018 #Osaka #Japan #August_08_09_2018 #Surgery #Nursing #Conferences Must attend #Event For more details PS: https://t.co/gPErZdaGfy @ASPS_News @IPSOSurgeons @UMichSurgery @MDT_Diabetes @iss_sic @JNJNews pic.twitter.com/IdDZG3IHvm

— Surgical Nursing (@NursingSurgical) April 13, 2018

@VerbSurgical @ethicon @JNJInnovation ONE Team great week in Korea and Japan discussing the future of surgery with leading surgeons. #roboticsurgery #digitalsurgery pic.twitter.com/gVXAaLqueI

— Verb Surgical (@VerbSurgical) December 8, 2017

Last session of #MDEpiNet Day 1 — robust panel on #CRNs for complex, cross-disciplinary devices ft. @JNJNews, @Medtronic, @US_FDA, academics and leaders from MDEpiNet-Japan chapter @hiro_stat @ksase pic.twitter.com/0X2zd26SUN

— MDEpiNet (@MDEpiNet_ppp) October 22, 2019

Fantastic variety of speakers here @SciFest4STEM in @CITScience4Life @Astro_Tani on Skype from Japan – Aine @Qualcomm and Gillian @JNJNews #STEMcareers #dowhatyoulove pic.twitter.com/UzCpbWQI2f

— SmartFutures (@SmartFuturesIE) April 20, 2018

Listening to inspiring keynote from Reiko Yajima, Ph.D. From SPARK Program @Stanford Translational Research School of Medicine #Kyoto #HVC 2019 #Japan @KyotoU_News @JLABS @JNJInnovation @AstellasUS @TakedaOncology @DNABARCODE @curaseninc pic.twitter.com/knKNuPfNAa

— Gitte Pedersen (@DNABARCODE) July 1, 2019

Even more great business connections at the #W20 #W20Japan with the @WEConnection Japan team and members and champions @JNJNews @JNJCares Japan together to support #WomensEmpowerment and #BuyWomenOwned pic.twitter.com/gqoSSJsvE1

— Elizabeth Vazquez (@CEOVazquez) March 26, 2019

Loved the #BusinessConnections made at the #W20 #W20Japan @WAW_Japan High-Level Panel on #WomenEntrepreneurs with great questions and support from @kagider @MEmpresarias @VdU_eV @ReemAlfrayan @apcoworldwide @Accenture @intel @MoodysCorp @JNJNews and @WEConnection Japan team pic.twitter.com/MnzxYCeDLy

— Elizabeth Vazquez (@CEOVazquez) March 24, 2019

Thanks to @intel @Accenture and @JNJNews for a successful @WEConnection launch event in #Japan! Thrilled to continue our collective work in advancing #SDG5 to empower #womenentrepreneurs around the globe! #WomenInBiz #SupplierDiversity #Tokoyo pic.twitter.com/jX4pBmHEFQ

— WEConnect Intl (@WEConnection) July 27, 2018

Today's news: #Trump optimistic for end to #tradewar with #China, US makes verbal #tradedeal with #Japan, @JNJNews hit with $572M fine for #OpioidEpidemic, #immigrationpolicy lawsuit, and Weinstein pleads not guilty to to charges | @kentcovington https://t.co/8qakIh9EjB pic.twitter.com/9IekWJ94kk

— WORLD Radio (@TWERadio) August 27, 2019

Since 2013, 2/3 of OECD countries introduced new policies on pay equality while Australia, UK, Japan, Germany & Sweden require some employers publish calcs showing gender pay gap annually. Hear about @JanssenANZ @JNJNews commitment 2gender equality & an inclusive & equal culture https://t.co/lpfslZbcKm

— Kathy Connell (@connell_kathy) March 15, 2018

Takeda @TakedaPharma agreed to sell its TachoSil surgical patch to privately held @CorzaHealth for €350 million.

This comes after the proposed deal between @TakedaPharma and @JNJNews did not go through owing to competition concerns by EU Commission.#Hemostats #BioSurgery https://t.co/jl6Udkk4PB

— Hemostats Expert (@HemostatsExpert) September 29, 2020

Top pharma execs discuss and share #bestpractices of what they're doing to meet the challenges of COVID-19 @LillyPad @JNJNews @Roche @Sanofi @Takeda @IFPMA https://t.co/HngTgXpJtH

— Ogilvy Cambridge (@OgilvyCambridge) March 20, 2020

Johnson & Johnson suspends plans of buying Takeda Pharmaceutical’s TachoSil. #JohnsonandJohnson #TachoSil #TakedaPharmaceutical #Ethicon #StockMarketNews #Coronavirus #FTC #EUregulators @JNJNews @JoeSimonsFTC https://t.co/ntJHplfl5J

— iNVEZZ (@InvezzPortal) April 11, 2020

Takeda Pays Turnstone $120M to Start Alliance on Viral Cancer Therapies https://t.co/6kS2ZzTEmp via @Xconomy @angelMD_Inc @tjarthur @CurtanaPharma @MDAndersonNews @DanaFarber @NCIResearchCtr @AmericanCancer @GlobalCancerTec @JNJGlobalHealth @JNJInnovation @TakedaOncology

— Joseph N Macaluso MD FACS (@MacalusoJoseph) December 24, 2019

Johnson & Johnson abandons deal for Takeda's TachoSil surgical patch https://t.co/U2lfUXtMXb pic.twitter.com/btbXD34kv3

— Reuters (@Reuters) April 10, 2020

Johnson & Johnson, Takeda and Evotec join The Dementia Consortium https://t.co/Hq5pLMyeht

— Oxford Science Park (@OxfordSciencePK) February 14, 2019

Takeda, Johnson & Johnson and more join Clara Health's Boston-based patient empowerment push https://t.co/h1dxLonXeK pic.twitter.com/qKePShTLoP

— FiercePharma (@FiercePharma) September 6, 2017

BiomX received $24 million financing from OrbiMed, Johnson & Johnson and Takeda – https://t.co/5s3Aq06DU0 pic.twitter.com/m8Bb96HlJz

— GMPnews.Net (@GMPnewsNet) May 15, 2017

Biotech innovation being accelerated by Israeli incubator FutuRx https://t.co/igdMCeNuh1 funded by #JJDC, Takeda, Orbimed @JNJInnovation pic.twitter.com/24TG9qGoju

— Marian T. Nakada (@MNakada) December 5, 2016

J&J, #Takeda team up to open #Israeli #biotech incubator http://t.co/3gSehrkyl5 .@JNJNews pic.twitter.com/GJM2IYgUi8

— AFHU (@AmFriendsHU) January 19, 2015

"What is next for the Russian market?" with CEOs from TEVA, @pfizer, Takeda, @drreddysnews & @JNJNews #RPF2014 pic.twitter.com/usWGWRaJ6K

— Russian Pharma (@PharmaASI) June 17, 2014

#Peptide_Based_Cancer_Therapeutics Market Size Worth $17.18 Billion By 2027

Read More : https://t.co/k5GadYh4D3

major market participants :@AstraZeneca @Allergan @Pfizer @Takeda @Amgen,@JNJNews #peptidetherapeutics #healthcare pic.twitter.com/8LF46fwnPm

— karishma mulani (@karishmamulani5) July 28, 2020

https://twitter.com/ResearchNews_24/status/1093484353416556544

AbbVie, Astellas, Eli Lilly, Johnson & Johnson, Merck, Takeda, Boehringer, Microsoft, Sanofi, Novo Nordisk, @broadinstitute, @BCBSMA are included on Working Mother magazine's "Best 100 Companies" 2019 list https://t.co/gCg9Q0xutk

— Pearl Freier (@PearlF) September 24, 2019

How do @JNJNews, Takeda, @novonordisk, top 10 differ from 21-30 in Productive Innovation?https://t.co/5I958cdYg1 pic.twitter.com/ifAeo0tgWe

— Mike Rea, IDEA Pharma (@ideapharma) March 8, 2016

@JNJNews tops pharma’s Productive Innovation Index. Gains made by @takedapharma, @abbvie, Otsuka, @novonordisk https://t.co/5I958cvz7z

— Mike Rea, IDEA Pharma (@ideapharma) March 2, 2016

Bayer files prostate cancer drug darolutamide in Japan: Bayer has filed its prostate cancer drug darolutamide with Japanese regulators, in an attempt to ratchet up the pressure on rivals Johnson & Johnson and Pfizer/Astellas. https://t.co/2lCBqd2A6q

— cafepharma (@cafepharma) March 5, 2019

New 'peptoids' show promise in resistant prostate cancer: A new generation of anti-androgen drugs such as Pfizer and Astellas’ Xtandi and Johnson & Johnson’s Zytiga have increased survival rates in metastatic castration-resistant prostate cancer (mCRPC).… https://t.co/FWKhBlnrCm

— cafepharma (@cafepharma) October 27, 2018

Bayer's Nubeqa scores key prostate cancer win in battle with Pfizer, J&J. Can this latest data help Nubeqa overcome it’s being third to market behind Pfizer and Astellas’ Xtandi and Johnson & Johnson’s Erleada? https://t.co/oCZsUjv3hh $PFE $JNJ $ALPMY $BAYN pic.twitter.com/q37wpJgj3U

— Bionest Partners (@BionestPartners) January 31, 2020

CANCER THERAPEUTICS Market: Types, Causes and Treatments | AbbVie, Inc., Johnson & Johnson, Celgene Corporation, Astellas Pharma, Inc. – Health News Office | @scoopit https://t.co/gqFeduAc4B

— Report Ocean (@ReportOcean) October 24, 2019

Cancer Treatment Drugs Market Size, Growth, Share and Top Players to 2026: Amgen, Roche, Novartis, Johnson & Johnson, Pfizer, Eli Lilly, Astellas https://t.co/9tASuYljgR pic.twitter.com/CxDF4MHAOF

— PressRelease.cc (@PressRelease_cc) October 1, 2019

.@Bayer has filed its prostate cancer drug #darolutamide with Japanese regulators, in an attempt to ratchet up the pressure on rivals Johnson & Johnson and Pfizer/Astellas https://t.co/bQctr3VxMs #pharmanews #oncology pic.twitter.com/GLUlkJqTEQ

— pharmaphorum (@pharmaphorum) March 8, 2019

Bayer has filed its prostate cancer drug darolutamide with Japanese regulators, in an attempt to ratchet up the pressure on rivals Johnson & Johnson and Pfizer/Astellas…. https://t.co/woWqLujfOV

— Pharma, Device Recruiting Asia (@MorundaGroup) March 6, 2019

Fibromyalgia Treatments Market 2019 – Major Participants: GlaxoSmithKline, Astellas Pharma, Johnson & Johnson, ALLERGAN, Sunovion Pharms, Jazz Pharmaceuticals, ABBOTT Etc – openPR #fms https://t.co/zq29d5nSue

— FMS News bot (@fmsbot) February 6, 2019

Pfizer, Astellas speed up 2 Xtandi studies in market duel with Johnson & Johnson. Will the acceleration of these trials help $PFE and Astellas in their competition with $JNJ in prostate cancer? #pcsm https://t.co/mejJGeIBBF pic.twitter.com/4Eoop5ngXb

— Bionest Partners (@BionestPartners) August 24, 2018

#Prostatecancer shake-up looms with new data from Pfizer, Astellas and Johnson & Johnson | FiercePharma https://t.co/jd4boefjnc by @FiercePharma pic.twitter.com/7x7em8AObz

— Advera Health (@AdveraHealth) February 19, 2018

Prostate cancer shake-up looms with new data from Pfizer, Astellas and Johnson & Johnson https://t.co/AaTJi402QB pic.twitter.com/0zZ7BTBpmL

— Pharmamarketeer (@Pharmamarketeer) February 9, 2018

Prostate cancer shake-up looms with new data from Pfizer, Astellas and Johnson & Johnson https://t.co/Omo8TfcJqm pic.twitter.com/0gM0pFY8fC

— RxDataScience Inc. (@RxDataScience) February 6, 2018

Global Castration Resistant Prostate Cancer Treatment Market 2017-2021 with Astellas Pharma, Johnson & Johnson,… https://t.co/CIpB5p1J75 pic.twitter.com/ExCDuuKlt7

— Business Wire-Health (@BW_Health) July 21, 2017

Ten big pharma – @Astrazenenca, @Gsk, @JNJNews, @Amgen, @Astellas, @Bayer, @Boehringer, @Merck, @Novartis, @Servier – join forces to use #AI for #drugdiscovery https://t.co/MDTfBQ5OTx #digitalHealth #blockchain #machinlearning #HealthcareIT

— PHARMAMEDIX (@PHARMAMEDIX) June 7, 2019

@JNJNews has the most bucks for #biopharma M&A, #Astellas the easiest target: analyst #biotech #biotechnology #pharma #healthcare #mergersandacquisitions #MandA $JNJ $GILD $PFE $AZN $NVS $MRK $BMY $AGN $RHHBY https://t.co/RtHZyoUJjq

— Kara Jill Stancell (@kjilly) May 29, 2018

As a major conference on tuberculosis nears, Doctors Without Borders is pressuring suppliers of key medicines — Johnson & Johnson, Mylan and Otsuka Pharmaceuticals — to lower their prices by significant amounts. https://t.co/oPYbMbRY2p

— STAT (@statnews) October 11, 2019

Schizophrenia Market Growth, Updated Business Strategies and Opportunities|Johnson & Johnson Services, AstraZeneca, Bristol-Myers Squibb Company/Otsuka Holdings Co. Ltd.https://t.co/BfOskoL0Od #news #pharma #pharmiweb

— Pharma News (@pharminews) July 31, 2020

Trending: Central Nervous System Therapeutic Market Size, Key Trends, Challenges and Standardization, Research, Key Players, Economic Impact and Forecast to 2026| Biogen, Pfizer, Teva, Novartis, Johnson & Johnson, EliLilly, Otsuka – 3rd … – https://t.co/um63Ln75cY

— General Physics Lab (@genphys) July 15, 2020

#tuberculosis Drugs Market: Competitive Intelligence and Tracking Report 2018-2026 | Major Players @JNJCares Johnson & Johnson Services, Lupin Ltd, @Novartis AG, Macleods Pharmaceuticals, Otsuka Pharmaceutical Co, @pfizer https://t.co/NELVSxfy25 pic.twitter.com/xc2TrxQthw

— Michael Jaikishan (@Michaeljaikish1) October 16, 2019

@PA_Consulting are with us this morning and they brought @AstraZeneca @JNJInnovation & Otsuka to meet with our @GotoGrow_London companies pic.twitter.com/IwUXNxV9Fu

— Alban REMY (@Alban_remy) June 27, 2017

Invokana (Canagliflozin; Johnson & Johnson/Mitsubishi Tanabe/Daiichi Sankyo) Drug Overview & Outlook 2016-2018 to 2025 – https://t.co/guyiBzPH8C https://t.co/GfBqliZcnY pic.twitter.com/xvb1KAUuda

— Latest News from Business Wire (@NewsFromBW) May 11, 2018

Invokana (canagliflozin; Johnson & Johnson/Mitsubishi Tanabe/Daiichi Sankyo) Drug Analysis 2018 – https://t.co/guyiBzPH8C https://t.co/utjYIBlmwL pic.twitter.com/UkJhLWVdgr

— Latest News from Business Wire (@NewsFromBW) March 29, 2018

Vitamin K Antagonists (VKA) Market 2025: Size, Share, Driving Factors, Revenue and Trends 2020| Sanofi, Daiichi Sankyo, Johnson & Johnson, Bristol-Myers Squibb, Lilly, Bayer – The Market Chronicles, https://t.co/0Ut1D4opSu #tech

— covidnews.ch (@covidnewsCH) September 10, 2020

https://twitter.com/HAccordingly/status/1221321860236955649

Global Stroke Treatment Market Report 2019-2027 Featuring Bristol-Myers Squibb, Boehringer Ingelheim, Daiichi Sankyo, Roche, Johnson & Johnson Services, Sanofi, Amgen, Biogen, and AstraZeneca https://t.co/5q9QUZCO2F

— NEWS FOR FOREX (@NEWSFORFOREX1) January 24, 2020

Global Anti-Hypertensive Drugs Markets 2015-2019 & Forecast to 2030 – Merck, Astra Zeneca, Daiichi Sankyo, Johnson & Johnson and Pfizer are the Major Players – https://t.co/8vPVgQlQhj https://t.co/9eCVTB5X9r

— Pharmacutical Daily (@PharmacDaily) November 7, 2019

US Anticoagulation Therapy Market |C. H. Boehringer Sohn (Germany), Bristol-Myers Squibb (US), Johnson & Johnson (US), Pfizer (US), Daiichi Sankyo (Japan), and Portola Pharmaceuticals (US) are the major market players https://t.co/s5ySyvfOIN pic.twitter.com/BcFaVkyaeo

— gajanan_s (@gajanans7) March 6, 2019

Alzheimer’s Disease Drug Market Trends, Analysis by Regions, Type, Application, Market Drivers, Restraints, and Top Key Players like Allergan, Eisai, Novartis, Daiichi Sankyo, Johnson & Johnson and Forecast to 2023 https://t.co/LipGE2ZEQc via @IndustryToday

— Industry Today (@IndustryToday) January 28, 2019

US Anticoagulation Therapy Market to 2022 – Major Players are C. H. Boehringer Sohn, Bristol-Myers Squibb, Johnson & Johnson, Pfizer, Daiichi Sankyo and Portola Pharmaceuticals https://t.co/0CWnNmUvzZ

— Seattle's Banker (@SeattlesBanker) November 17, 2017

#NTD supply chain at #Merck attended by #Eisai, @pfizer @GSK #MSD @JNJNews @DeutschePostDHL on #schistosomiasis pic.twitter.com/ViNezXdIKC

— Merck (@merckgroup) June 28, 2016

The #pharma companies involved are: @GSK, Eisai, @JnJnews, @Merck & Co., Merck KGaA, @pfizer.

— Access to Medicine Foundation (@AtMIndex) November 17, 2014

#WIPOReSearch Member companies Eisai, GSK, Johnson & Johnson, and Takeda featured in November Partnership Hub Snapshot. Advancing drug discovery around #NTDs, #malaria, and #tuberculosis. https://t.co/rtLTaYv0uA @Eisai_SDGs, @GSK, @JNJGlobalHealth, @TakedaPharma, @WIPO pic.twitter.com/mnm0AJo3Ai

— BVGH (@BIOVentures) November 12, 2019

Really glad to support the World Metastasis Summit and join AstraZeneca, The Janssen Pharmaceutical Companies of Johnson & Johnson, Eisai US…#oncology #metastasis #drugdiscovery #inovotion #preclinical #medicalsciences #research https://t.co/8wKH9ozRer

— Philippe Fornies (@ForniesPhilippe) September 18, 2019

Global Lennox-Gastaut Syndrome Treatment Market 2019-2023 – Key Players are Eisai, GlaxoSmithKline, H. Lundbeck, Johnson & Johnson Services, and Supernus Pharmaceuticals – https://t.co/SdubibH8Fr – Associated Press https://t.co/xSlG3H7own

— IDRO (@IDROOhio) April 22, 2019

Global Lennox-Gastaut Syndrome Treatment Market 2019-2023 – Key Players are Eisai, GlaxoSmithKline, H. Lundbeck, Johnson & Johnson Services, and Supernus Pharmaceuticals – https://t.co/guyiBzPH8C https://t.co/WFXbokdAZH pic.twitter.com/KRmMxi9gLs

— Latest News from Business Wire (@NewsFromBW) April 22, 2019

Major pharmaceutical companies including Eisai, GlaxoSmithKline, Johnson & Johnson, Merck, and Pfizer have given billions of dollars’ worth of pharmaceutical products, as well as cash, to help eliminate global diseases. https://t.co/xv4DFMIcbN

— The Chronicle of Philanthropy (@Philanthropy) October 1, 2018

Well done BD, bioMérieux, Boehringer Ingelheim, Bristol-Myers Squibb, Eisai, Eli Lilly, Gilead, GSK, Johnson & Johnson, Merck (known as MSD outside the U.S. and Canada), Merck KGaA, Novartis, Pfizer, and Sanofi. https://t.co/f4ATL9azds

— Adam P Roberts (@GCAGATGCAATG) March 26, 2020

U.S.A. アメリカ Vol.113（Massachusetts マサチューセッツ州 Vol.2: pharmaceutical corporations 製薬会社）

All the below links and tweets are in English.

取り急ぎ以下貼っておきます。

Massachusetts Vol.19 (corporations: Moderna)
Massachusetts Vol.20 (corporations: Biogen)

ツイッター検索で上記2製薬会社各社名及び Japan や日本の5製薬会社各社名を入れて出て来たもの

Moderna Confirms Discussions with the Ministry of Health, Labour and Welfare to Supply Japan with 40 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273): https://t.co/jpsGTOv9BQ pic.twitter.com/fo0XC7pCXo

— Moderna (@moderna_tx) August 28, 2020

.@TakedaPharma sets up deal to distribute @moderna_tx’s #COVID19 #vaccine in Japan: https://t.co/h7QCDUi89A

—#biomanufacturing #bio #biopharma #pharmaceutical #pharma #healthcare #manufacturing #coronavirus #pandemic pic.twitter.com/sTJPWEkjXv

— American Biomanufacturing (@BioMfg) September 2, 2020

Moderna to potentially supply Japan with 40M doses of COVID-19 vaccine @moderna_tx https://t.co/pRlHBWh3uk

— The Science Advisory Board (@ScienceBoard) August 28, 2020

American biotech company @moderna_tx has confirmed it is in discussions with #Japan's government over the potential purchase of 40 million or more doses of COVID-19 #vaccine.https://t.co/XKNJ7uC317

— The Jerusalem Post (@Jerusalem_Post) August 28, 2020

The #US-based biotech company #Moderna (@moderna_tx) has confirmed talks to supply 40 million doses of its potential #COVID19vaccine to #Japan. pic.twitter.com/qYDWaNTdQm

— IANS Tweets (@ians_india) August 30, 2020

“The [@moderna_tx] #vaccine candidate… would be distributed in Japan by @TakedaPharma, beginning in the first half of 2021… #Japan has already signed agreements with other drugmakers such as @Pfizer & @AstraZeneca, as well as local ones like #Shionogi & Co…” #COVID19 https://t.co/awQJyQhnpN

— Mark Warner (@MAAWLAW) August 28, 2020

COVID-19 Vaccine Pipeline https://t.co/z9QJ2v4RBj via @kyodo_english #WHO @moderna_tx #NIAID @InovioPharma @BioNTech_Group #ClinicalResearch "Even if overseas vaccines have success and received special regulatory approval, the supply in Japan will be limited"

— ClinicalBid (@ClinicalBid) June 30, 2020

We are proud to announce that we are working with @biogen Japan LTD. to create a system to respond faster and more accurately to questions from patients, the media, physicians & other constituents at its Medical Information Department (MID).

Read more: https://t.co/7R11MuIgCa

— Lexalytics (@Lexalytics) September 18, 2019

Program two "Gene Lab" @miraikan in Japan- Students worked on experiments w/electrophoresis and recombining DNA! #STEM #HandsOnScience pic.twitter.com/9AZ3JUGqgg

— Biogen (@biogen) March 21, 2017

Our Rare Disease treatment is now approved across the globe in Australia, Brazil, Canada, EU, Japan, Switzerland and the US #ProudMoments2017 pic.twitter.com/5lyBePTfYs

— Biogen (@biogen) December 22, 2017

Heading to Japan to be part of #WCN17 focused on the future of #neurology. Follow @Biogen for the latest! pic.twitter.com/A4yU2kFTci

— Biogen MS (@biogenms) September 15, 2017

Exciting moments w/ students @miraikan in Japan during "Gene Lab" hands-on experiment events – “E-coli glowing in the dark”! #STEM #Science pic.twitter.com/ak7wee6o7L

— Biogen (@biogen) March 13, 2017

Great to have @BiotechTour ambassadors & @miraikan representatives at our Japan office @sciencecenters #WBT2015 #STEM pic.twitter.com/MwPNSmJ9TH

— Biogen (@biogen) August 3, 2015

.@BiotechTour 2015 continues with it's next stop in Tokyo, Japan @miraikan (August 8 ceremony) http://t.co/12YAJjg4zn #WBT2015 #STEM

— Biogen (@biogen) July 28, 2015

An amazing day at @miraikan WBT festival! Thank you @biogen and @ScienceCenters for your support in Japan #WBT2015 pic.twitter.com/mqNeOMi9nU

— WorldBiotechTour (@BiotechTour) August 8, 2015

This year we celebrated our 40th anniversary with events in the U.S., Japan and Switzerland. Almost 2K employees, experts, physicians, patients and reporters were able to join us to reflect on the important moments that shaped our past, and our bright future. #ProudMoments2018 pic.twitter.com/iTnlHrhFZz

— Biogen (@biogen) December 11, 2018

#DRG epidemiology report estimates more than 15,000 people diagnosed with #SMA across the United States, Western Europe and Japan. Detailed report available now @DRGinsights #spinalmuscularatrophy #RareDiseaseDay @biogen https://t.co/PguIonrUSW

— DRG Epidemiology (@DRG_Epi) March 5, 2020

#DRG epidemiology report estimates more than 15,000 people diagnosed with #SMA across the United States, Western Europe and Japan. Detailed report available now @DRGinsights #spinalmuscularatrophy #EAN2019 @biogen https://t.co/vNfzsxdEAd

— DRG Epidemiology (@DRG_Epi) July 3, 2019

#DRG epidemiology report estimates more than 35,000 diagnosed prevalent cases of #amyotrophiclateralsclerosis across the United States, Western Europe and Japan. Detailed report available now @DRGinsignts #ALS #WorldALSDay @biogen https://t.co/pE5tSpaPpw

— DRG Epidemiology (@DRG_Epi) June 24, 2019

More than 10 million people are living with #Alzheimersdisease across the United States, Western Europe and Japan. Stay tuned for more updates on #DRG global epidemiology data @DRGinsights @biogen #AlzheimersAwarenessMonth https://t.co/MmNdFkPrzQ

— DRG Epidemiology (@DRG_Epi) November 6, 2018

How about a deal with @SangamoTx to better exploit protein homeostasis? Hematology is unpartnered @ScienceAtBMS @bmsnews @JoeSzustakowski.
Partners include @sanofi @NovartisScience @pfizer #takeda @GileadSciences @KitePharma @biogen $SGMO $BMY $PFE $NVS $SNY $GILD $BIIB https://t.co/tJzQPwFTgB

— biotech 2050 (@Biotech2050) July 30, 2020

Open Targets is 5 and we would like to thank all our 355 staff from our partners @biogen @celgene @emblebi @GSK @takeda @sanofi @sangerinstitute + guest institutions for contributing & being part of such successful #precompetitive community. Here's to many more years to come! pic.twitter.com/eiVhWWVlXx

— Open Targets (@targetvalidate) June 21, 2019

Takeda joins Open Targets drug discovery initiative. @targetvalidate @TakedaPharma @GSK @emblebi @biogen https://t.co/XOHP4TPSpX pic.twitter.com/qPW97LuHPW

— Sanger Institute (@sangerinstitute) December 5, 2017

The Dementia Discovery Fund first launched in 2015 with $100 million in capital from a range of Big Pharma companies, the U.K. government and the non-profit Alzheimer's Research UK @Biogen @GSK @Johnson&Johnson @Lilly @Pfizer @Takeda @ARUK @DHSCgovuk https://t.co/tdtENajGGx

— The Dementia Discovery Fund (@TheDDFund) August 9, 2018

.@TheDDFund $350M raise included $60M from @AARP as part of its #DisruptDementia initiative; fund spearheaded by #biopharma group that included @biogen @LillyPad @GSK @JNJNews Otsuka @pfizer @TakedaPharma

— BioWorld (@BioWorld) June 25, 2018

Former @biogen R&D guy @michael_gilman has a new biotech today, Obsidian, founded in 2015 by Atlas. A $50M Series A round was led by GV, the venture arm of Alphabet, & includes Atlas and the venture arms of Takeda and Amgen. by @BosBizMax https://t.co/HPYNg8DZaA

— Don Seiffert (@BosBizDon) December 6, 2017

#Biotech Industry in #Boston Reacts to #Coronavirus, Implements Containment Measures | @Biogen execs instructed to quarantine and isolate themselves from loved ones, and @Takeda implementing work-from-home for workforce | #COVID19 #SARSCoV2 #2019nCoV https://t.co/80oCHVVDbN

— Patrick Henry Warren (@phwarren360) March 9, 2020

https://twitter.com/bmd_congress/status/1165337983094067201

Great news that Takeda has joined the Open Targets drug discovery initiative. More here: https://t.co/XOHP4TPSpX @targetvalidate @TakedaPharma @GSK @emblebi @biogen https://t.co/8SFnDO41B2

— Sanger Institute (@sangerinstitute) December 5, 2017

ADI would like to thank our supporters whose generosity enabled us to run yet another successful #WorldAlzMonth campaign; in particular, Acadia Pharmaceuticals, @biogen, @JanssenUK, @Lundbeck, Otsuka & @Roche. Thank you! pic.twitter.com/Pej52CpUhz

— ADI (@AlzDisInt) October 2, 2020

Eisai is creating a new US corporate, R&D HQ in Roche’s old Nutley, NJ campus | @Roche @Eisaius @Biogen @Quest @HMHNewJersey @hallnursing #Nutley #NewJersey #Cambridge #Massachusetts #Biotech #neurodegenerative #diabetes #cancer #alzheimer #parkinson https://t.co/ce0EkdSrJF

— Aspen Biosciences (@aspenbio) August 12, 2020

Eisai is creating a new US corporate, R&D HQ in Roche’s old Nutley, NJ campus | @Roche @Eisaius @Biogen @Quest @HMHNewJersey @hallnursing #Nutley #NewJersey #Cambridge #Massachusetts #Biotech #neurodegenerative #diabetes #cancer #alzheimer #parkinson https://t.co/IkXPDuB59M

— Pharm2Market (@pharm2market) August 12, 2020

Biogen and Eisai Complete the Submission of BLA to the US FDA for Aducanumab to Treat Alzheimer’s Disease @biogen @EisaiUS https://t.co/A9YmZfSPUW pic.twitter.com/rGx3wODNiz

— PharmaShots – Incisive news in 3 shots (@Pharmashot) July 9, 2020

Biogen and Eisai Terminate P-III ENGAGE and EMERGE Study for Alzheimer’s Disease @biogen https://t.co/nSOsjsoRZo pic.twitter.com/WrFji1EsGZ

— PharmaShots – Incisive news in 3 shots (@Pharmashot) March 22, 2019

Biogen, Eisai seek priority US #FDA review of #Alzheimer's drug @biogen https://t.co/1w1SRBawS1 pic.twitter.com/1rd7XK4AdE

— Market Intelligence: Healthcare (@SPGMIHealthcare) July 9, 2020

Global #Alzheimers #Drugs Market 2019 — Eisai Pharmaceuticals, @Allergan, Amgen, @Biogen https://t.co/g6tC6YC5KB

— Marketstudy (@Marketstudy1) October 25, 2019

Biogen, Eisai revive plans for Alzheimer’s drug #Alzheimers @biogen https://t.co/0ChzgxABqB

— Pharmacy Business (@PharmacyBiz) October 24, 2019

This is incredibly disappointing news, but just another reason we have to keep up the fight. Alzheimer's is relentless, so are we. #endalz @biogen @eisai

Biogen, Eisai End Two Late-Stage Trials for Alzheimer’s Treatment https://t.co/skleIwPUcw

— Carey Ann Comeau (@careyanncomeau) September 17, 2019

Due to unfavorable risk-benefit, @Eisai_SDGs & @biogen discontinue Ph3 #clinicaltrials of #elenbecestat vs early #Alzheimers #BACE inhibitor was studied in patients w/ mild #cognitive impairment or mild AD + #amyloid pathologyhttps://t.co/MPKXpGK141 #neuroscience #dementia pic.twitter.com/ik4Dc4JCpH

— DDNews Online (@DDNewsOnline) September 13, 2019

Eisai kickstarting alternate Alzheimers’ drug after failure of Aducanumab: https://t.co/ccyHcYCEKl @FierceBiotech @EisaiUS @Biogen #Alzheimers #mentalhealth #drugdiscovery #medicine

— NCBCenter (@NCBCenter) March 27, 2019

@Eisai_SDGs, @biogen kick-off phase 3 testing early #Alzheimer's disease antibody, amid dropping #aducanunab trial https://t.co/jmNie2FFf8 pic.twitter.com/8PFtoy4mgr

— Pharmacutical Daily (@PharmacDaily) March 22, 2019

https://twitter.com/HeidiCreighton/status/1109772708148113409
https://twitter.com/HeidiCreighton/status/1109064555542523906

Disappointing news, @biogen and Eisai have announced the decision to discontinue the EMERGE and ENGAGE Phase III clinical studies of #aducanumab in #Alzheimer’s diseasehttps://t.co/b0pCqyNZFc pic.twitter.com/uZjfSsaCwL

— Alzheimer Europe (@AlzheimerEurope) March 21, 2019

Biogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of aducanumab in Alzheimer’s Disease https://t.co/9aYlZeFYCV @biogen @EisaiUS More life science business news at [LSUS] at https://t.co/WILuBJwPqp pic.twitter.com/a4tJEPaJ1m

— [iito] Life Science (@iitoLifeScience) March 21, 2019

“We used to have to squint and look at things to feel like, ‘OK, maybe this could work.’ I think this is really giving us a real feeling that we’re making a lot of progress,” PMC's Dr. David Wolk told @whyy regarding the @biogen/Eisai research results. https://t.co/cKjfs4vtDN

— Penn Memory Center (@Penn_Memory) July 31, 2018

Eisai Co. & @Biogen revealed data showing their experimental drug slows the progression of #Alzheimers, but experts like PMC Co-Director @jasonkarlawish say they would like to see a larger, longer study conducted to further assess risks and benefits. @WSJ https://t.co/L1e06YnWjn

— Penn Memory Center (@Penn_Memory) July 30, 2018

.@biogen and Eisai's #Alzheimers drug demonstrated in a clinical trial that it significantly slowed cognitive decline and more for #pharma #marketers to know. $BIIB $GILD $AMGN #healthcare #HealthInsurance https://t.co/QebzaE0NAb pic.twitter.com/zHPfvrOsBx

— MM+M Magazine (@MMMnews) July 26, 2018

News for #pharma #marketers: Thurs, July 26
– @biogen and Eisai's #Alzheimers drug slows cognitive decline
– @GileadSciences CEO to step down
– @Amgen #migraine treatment faces difficulties with insurers$BIIB $GILD $AMGN #healthcare #HealthInsurance https://t.co/QebzaDJcID pic.twitter.com/p8HskyIm4K

— MM+M Magazine (@MMMnews) July 26, 2018

.@Biogen and Japanese drugmaker Eisai created a surge in hope for an experimental #Alzheimers drug called BAN2401, after the companies announced positive results in a late-stage trial. But did the market overreact to the #data? #pharma #healthcare https://t.co/FlAEq43bX5 pic.twitter.com/KWgtEpyMsO

— MM+M Magazine (@MMMnews) July 14, 2018

Eisai and Biogen's Alzheimer's drug slows progression in Phase 2 trials https://t.co/q34CgTkBpR #AlzheimersDisease #Alzheimers #Phase2 @EisaiUS @biogen

— Pharmafocus (@Pharmafocus) July 26, 2018

Looks like Investors, analysts remain to be convinced over @EisaiUS @Biogen's #BAN2401 in #AlzheimersDisease even after more details of promising Phase II data

Biogen, Eisai Report BAN2401 Seemingly Positive In Alzheimer's; Others Skeptical https://t.co/YYao6VbYT2

— Ian Haydock (@ScripIanHaydock) July 26, 2018

Results of @Biogen and #Eisai clinical trial show #Alzheimers treatment reduced buildups of amyloid plaque in the brain by 93% and slowed progression of the disease 30-47% https://t.co/NIOMoy3SYG $BIIB pic.twitter.com/fwfkvkWzSM

— Jeff Cotrupe (@jeffcotrupe) July 25, 2018

Clinical trial results are in! Eisai & Biogen Announce Positive Topline Results of the Final Analysis for BAN2401 at 18 Months @biogen https://t.co/kaoS6IQKJR pic.twitter.com/4glbrp4Hc7

— Neural Cell News (@NeuralCell) July 13, 2018

Eisai and @Biogen announce positive phase 2 Alzheimer’s data on BAN2401 anti-amyloid beta protofibril antibody. Patients exhibited slowdown in symptoms and reduced plaque in the brain. https://t.co/19Vp6MgFLI Good news and verification of amyloid beta as a therapeutic target

— Upperton (@UppertonLtd) July 12, 2018

We're closer than ever to treating #Alzheimer's with two drugs from @Biogen and @Eisai that do what #BigPharma hasn't been able to yet. https://t.co/uEccuWjPRX

— Tech2 (@tech2eets) July 10, 2018

@EisaiUS and @biogen Phase 2 trial for BAN2401 in #Alzheimers #patients, GlobalData figures say the global Alzheimer’s market will reach $14.8bn by 2026, so Eisai and Biogen can still expect to achieve significant sales for their product. https://t.co/mNRhbYywLU

— GlobalData Pharma (@Pharma_GD) July 6, 2018

@biogen @EisaiUS news – a win for the #amyloid hypothesis "BAN2401 Results Validate Eisai/Biogen's Faith In Alzheimer's Amyloid Tack" via @PharmaScrip #Alzheimers pic.twitter.com/b7Srr8hCf6

— OptimumComms (@OptimumComms) July 6, 2018

https://twitter.com/akalali/status/1015103726577639424

#Eisai – #Biogen to advance #Alzheimers drug, provide fresh hope https://t.co/UHQLpoVTGA #ETHealthworld @ETHealthWorld @biogen #BAN2401 #AlzheimersDisease #pharma

— Plexus Ventures (@PlexusVentures) July 25, 2018

@biogen takes up option to co-develop #Eisai #AD drug https://t.co/mfwmLP2VXu @PharmaTimes #AlzheimersDisease #aducanumab

— Plexus Ventures (@PlexusVentures) October 25, 2017

Eisai sells RTP facility to @Biogen; results in 35 layoffs http://t.co/iqBdzh1Ski pic.twitter.com/m7S3Xolkzy

— Boston Business Journal (@BosBizJournal) July 16, 2015

#Leukemia_Therapeutics_Market: Growing at a CAGR of 6.6% over the forecast period of 2019-2025.
For More Details: https://t.co/jmnagRx2bn @Celgene @Eisai_SDGs @SanofiGenzyme @bmsnews @Novartis_AG @biogen @Roche @GSK @pfizer pic.twitter.com/BtaRV399Eb

— Infinium Global Research (@infiniumglobal1) August 24, 2019

Very interesting consensus white paper from @MichaelJFoxOrg: A proposed roadmap for #Parkinsons proof of concept clinical trials investigating compounds targeting alpha synuclein – @biogen @VAInstitute @Eisai @LumosPharma @JCedarbaum @BrundinPatrik https://t.co/5h4mu4a70F pic.twitter.com/ozaqisV10M

— ScienceofParkinsons (@ScienceofPD) November 8, 2018

Would this treatment resolve these issues from #Inflammation as well?#Dementia @nih_nhlbi @biogen @EisaiUS @eisai @HopkinsMedNews https://t.co/V7k8ZwqTBd pic.twitter.com/79WFvREHz3

— BW (@fxrseen) July 6, 2018

U.S.A. アメリカ Vol.112（US Vice Presidential Debate 10/7/2020 ― 副大統領候補テレビ討論会）

All the below tweets (@usatodayDC, @DailyCaller, @Newsweek, @NRO, @nypost, etc.) are in English. [hosted by @UUtah]

The 90-minute exchange, the only vice presidential debate of the 2020 cycle, became – as expected — a battle over President Donald Trump https://t.co/Ajm0ZQsTDS

— USA TODAY Politics (@usatodayDC) October 8, 2020

Sen. Kamala Harris discusses her law enforcement and criminal justice record to Vice President Pence during the VP debate. https://t.co/JV5fpCLwxW

— USA TODAY Politics (@usatodayDC) October 8, 2020

The Vice Presidential debate had less arguing and a lot more talk about the issues, but there were still a few heated moments. https://t.co/aSaOYUEzL3

— USA TODAY Politics (@usatodayDC) October 8, 2020

Sen. Kamala Harris and Vice President Pence discuss Trump's comments regarding white supremacist organizations from the previous presidential debate. https://t.co/ehY0Da0sjc

— USA TODAY Politics (@usatodayDC) October 8, 2020

"These are torturous times, but we can and will have a respectful exchange about the big issues," said moderator Susan Page to begin the debate. https://t.co/hbtdZ1nqBC

— USA TODAY Politics (@usatodayDC) October 8, 2020

Sen. Kamala Harris said she does not believe Breonna Taylor received justice. Vice President Mike Pence said he trusts the justice system. https://t.co/nVIrCP8xnS

— USA TODAY Politics (@usatodayDC) October 8, 2020

Vice president Mike Pence and Democratic vice presidential nominee Kamala Harris hit each other on taxes, climate change and the COVID-19 responses. https://t.co/UL9DeY9B3p

— USA TODAY Politics (@usatodayDC) October 8, 2020

The clash between Kamala Harris and Mike Pence was evident even through their body language during the vice presidential debate. https://t.co/OyQyuDkq6f

— USA TODAY Politics (@usatodayDC) October 8, 2020

Pence said that "many of the people" at the event were tested for coronavirus and pointed out that the event was outdoors. https://t.co/kv5NVYmnMI

— USA TODAY Politics (@usatodayDC) October 8, 2020

Sen. Kamala Harris said she would only take a COVID-19 vaccine on the advice of public health professionals. https://t.co/dx44Ov7K3G #VPDebate pic.twitter.com/nl2rHvq5be

— USA TODAY Politics (@usatodayDC) October 8, 2020

Pence has served as a bridge to social conservatives and members of the GOP establishment who were wary of Trump. He’s also been a calmer, steadier and more predictable communicator than Trump. https://t.co/fEAk7q6jUk

— USA TODAY Politics (@usatodayDC) October 8, 2020

Pence, who briefly practiced law, was primarily a radio talk show host and head of a conservative think tank before elected to Congress. https://t.co/KyzlLW1vk2

— USA TODAY Politics (@usatodayDC) October 8, 2020

Many viewers were quick to send tweets, with some joking that the fly should get time to respond to the questions. https://t.co/0wlowtKtGp

— USA TODAY Politics (@usatodayDC) October 8, 2020

During the #VPDebate2020 a fly sat on the top of Mike Pence’s head for several minutes while he debated Kamala Harris: https://t.co/NauW2PHGhB pic.twitter.com/MguROAWbd1

— USA TODAY (@USATODAY) October 8, 2020

Pence tried to get Harris to answer a question that she and Biden have been dodging: Do they support expanding the Supreme Court as many liberals are advocating?

He said the public deserves to know, calling it a case of trying to change the rules if you can’t win by the rules. pic.twitter.com/Jvbk5WqbAt

— USA TODAY (@USATODAY) October 8, 2020

Kamala Harris Pushes Unverified Story About Russian Bounties On American Troops In The Middle East https://t.co/zZoaXk1z6e

— Daily Caller (@DailyCaller) October 8, 2020

Pence Highlights Harris’ Attacks On Kavanaugh, Democratic Attacks On Amy Coney Barrett https://t.co/okx4Df7PrG

— Daily Caller (@DailyCaller) October 8, 2020

"Vice President Pence appeared flaccid," says MSNBC's Nicolle Wallace pic.twitter.com/MNYJ0IkWLw

— Daily Caller (@DailyCaller) October 8, 2020

Moderator Susan Page Asks 0 Questions About Kamala Harris Raising Money For Bail Fund That Helped Release Domestic Abusers https://t.co/uDsAJactyA

— Daily Caller (@DailyCaller) October 8, 2020

Kamala Harris Refuses To Answer Question On Packing The Supreme Court https://t.co/UvyvrMpVAK

— Daily Caller (@DailyCaller) October 8, 2020

ABC's George Stephanopoulos:

"A lot of people were noticing some mansplaining going on tonight." pic.twitter.com/5FtQlyxL9p

— Daily Caller (@DailyCaller) October 8, 2020

Harris Repeats She Will Not Trust Trump Backed Vaccine https://t.co/s26HwMp5yj

— Daily Caller (@DailyCaller) October 8, 2020

PENCE: "When you talk about accepting the outcome of the election, I must tell you, Senator, your party has spent the last three and a half years trying to overturn the results of the last election." pic.twitter.com/zrquOgjKz4

— Daily Caller (@DailyCaller) October 8, 2020

Kamala Harris Repeats Lie That Trump Called Virus A ‘Hoax’ https://t.co/hdrb3lwDYO

— Daily Caller (@DailyCaller) October 8, 2020

Kamala Harris repeatedly dodges the court packing question. Instead goes on a tangent about how "of the 50 people who President Trump appointed to the court of appeals for lifetime appointments, not one is black." pic.twitter.com/F3ZZvWUU34

— Daily Caller (@DailyCaller) October 8, 2020

Fly Lands On Mike Pence’s Head During Vice Presidential Debate https://t.co/x9e7cb2ujZ

— Daily Caller (@DailyCaller) October 8, 2020

Live updates vice presidential debate: Mike Pence and Kamala Harris face off in Salt Lake City https://t.co/6B7FejOIjK

— Newsweek (@Newsweek) October 8, 2020

Who won the vice residential debate between Pence and Harris? Analysis and highlights https://t.co/MTRFHLC1pt

— Newsweek (@Newsweek) October 8, 2020

Kamala Harris was more truthful than Mike Pence In debate, Newsweek reader poll shows https://t.co/DTf0aHezGc

— Newsweek (@Newsweek) October 8, 2020

Mike Pence and Kamala Harris are neck and neck in the polls going into the debate https://t.co/oDHu6RQTZQ

— Newsweek (@Newsweek) October 8, 2020

Video resurfaces of Kamala Harris saying she wants to ban fracking after saying Biden will not during VP debate https://t.co/4OOjyXipTM

— Newsweek (@Newsweek) October 8, 2020

Kamala Harris dodges Supreme Court packing question while Pence is evasive on peaceful transfer of power https://t.co/eM8jHUwgsO

— Newsweek (@Newsweek) October 8, 2020

Fact Check: Does Joe Biden support the Green New Deal and a fracking ban? https://t.co/14Mrgb8NZv

— Newsweek (@Newsweek) October 8, 2020

Fact Check: Did Joe Biden say he would repeal the Trump tax cuts? https://t.co/O6Vk4XtNFC

— Newsweek (@Newsweek) October 8, 2020

Kamala Harris memes flood internet as her reactions to Mike Pence go viral https://t.co/hxhN3S6xPk

— Newsweek (@Newsweek) October 8, 2020

AOC slams GOP for Green New Deal "lies" during VP debate, says it will be a massive job creator https://t.co/6RUOboD54X

— Newsweek (@Newsweek) October 8, 2020

Biden's campaign launches https://t.co/DeVCSkvmrD, sells swatters after fly lands on Pence's head during debate https://t.co/NQrnNZ4cb1

— Newsweek (@Newsweek) October 8, 2020

Mike Pence had a fly on his head during the VP debate and the internet erupted https://t.co/0SmKc3AOTz

— Newsweek (@Newsweek) October 8, 2020

Harris Opens Debate by Labeling Trump’s COVID Response ‘Greatest Failure’ of any Administration in History https://t.co/eBPAfGEM8v pic.twitter.com/W056w1Il3x

— National Review (@NRO) October 8, 2020

Harris Joins Biden in Refusing to Say Whether She Supports Packing Supreme Court https://t.co/Vir6ip5mDJ pic.twitter.com/SUimeJl5cg

— National Review (@NRO) October 8, 2020

A Good Night for Mike Pence . . . That Probably Won’t Change Very Much https://t.co/qmc8GYMfDc via @jimgeraghty pic.twitter.com/yZYtMjv9lZ

— National Review (@NRO) October 8, 2020

Kamala Harris’s Dishonesty on Abe Lincoln https://t.co/A3SFEve5Nh via @baseballcrank

— National Review (@NRO) October 8, 2020

NR Tweets the 2020 Vice Presidential Debate https://t.co/Jk9uTd5CdE

— National Review (@NRO) October 8, 2020

"I support a Green New Deal" – @SenKamalaHarris pic.twitter.com/DNScm5eD19

— Senate Republicans (@SenateGOP) October 8, 2020

Here's what you need to know about tonight's debate: Mike Pence shouldn't even be there https://t.co/V0lEbAUH3h

— Salon (@Salon) October 8, 2020

Debate recap: No one will ban fracking, but what exactly will they do to tackle climate change? https://t.co/rZjI2UzQzv

— grist (@grist) October 8, 2020

No, Biden has not agreed to ban fracking. https://t.co/G7bsBK1Lzl

— grist (@grist) October 8, 2020

Thanks for following along with our live coverage of the #VPDebate.

Join us next time! pic.twitter.com/BjYtG9Egdc

— American Progress (@amprog) October 8, 2020

Whether it's investing in science or providing free community college, Joe Biden & #Kamala Harris will invest in the American people.#VPDebate pic.twitter.com/6tTYvvMunz

— MoveOn (text POWER to 668366) (@MoveOn) October 8, 2020

FACT CHECK #VPDebate ⤵️ pic.twitter.com/XSv6Cis65v

— The Democrats (@TheDemocrats) October 8, 2020

Trump tweets Mike Pence 'won big' at VP debate https://t.co/F8UG5g36Do pic.twitter.com/3MLXSaVou4

— New York Post (@nypost) October 8, 2020

Who won the VP debate? Experts grade Kamala Harris vs. Mike Pence https://t.co/XgP0s5P8Gq pic.twitter.com/Jhos0TVKSp

— New York Post (@nypost) October 8, 2020

Mike Pence slams Kamala Harris for her racial disparities as prosecutor https://t.co/aXbMfsSXnI pic.twitter.com/I6r7dNY54j

— New York Post (@nypost) October 8, 2020

Pence tells Kamala Harris that Trump was slandered by Atlantic https://t.co/bRc3oQm6zH pic.twitter.com/IdgrbXNnFS

— New York Post (@nypost) October 8, 2020

Pence, Trump attack Biden for opposing Bin Laden raid https://t.co/vwYEXvDY2b pic.twitter.com/4yMJHRNkwG

— New York Post (@nypost) October 8, 2020

Moderator Susan Page struggles to steer vice presidential debate https://t.co/DUtK5pNzgS pic.twitter.com/23O5bCMSrt

— New York Post (@nypost) October 8, 2020

Pence rips Biden’s failure to tackle ISIS, cites Kayla Mueller at debate #Debates https://t.co/6OlDcgMmuo pic.twitter.com/LYWuT43TSD

— New York Post (@nypost) October 8, 2020

Trump blasts Harris as a ‘gaffe machine’ in VP debate live-tweet #Debates https://t.co/6WTMYf5VxI pic.twitter.com/xkO8dmwvT9

— New York Post (@nypost) October 8, 2020

Mike Pence says Americans ‘have a right to know’ about Trump’s health during VP debate #Debates https://t.co/PCXALMrnXx pic.twitter.com/mRX4vzwCsf

— New York Post (@nypost) October 8, 2020

Trump weighs in on VP debate with fracking fact-check https://t.co/mG1X9B44RG pic.twitter.com/VjgTpBFiPk

— New York Post (@nypost) October 8, 2020

Pence: The American economic ‘comeback is on the ballot’ #Debates2020 https://t.co/MQF9JELSKE pic.twitter.com/h1npmoUJ9U

— New York Post (@nypost) October 8, 2020

Kamala Harris on COVID vaccine: Won’t take it if Trump tells me to #Debates2020 https://t.co/koiCAiU2dc pic.twitter.com/KsX54fdvEj

— New York Post (@nypost) October 8, 2020

Pence rips Harris for undermining COVID-19 vaccine at vice presidential debate https://t.co/69yyXlMNV9 pic.twitter.com/mYvMS8gbOE

— New York Post (@nypost) October 8, 2020

Biden campaign cashes in on Mike Pence's debate night fly https://t.co/dazZSKD87l pic.twitter.com/vqZ8kIwX3h

— New York Post (@nypost) October 8, 2020

Before Mike Pence, Hillary Clinton had her own fly debate moment https://t.co/plcJIuVF8Y pic.twitter.com/JWcU9oBqW7

— New York Post (@nypost) October 8, 2020

Fly lands on Pence's head, steals the show during VP debate https://t.co/0oGd1WouUW pic.twitter.com/ZgstjTEoD1

— New York Post (@nypost) October 8, 2020

'Undecided' voters at NBC town hall were reportedly Joe Biden supporters https://t.co/XRIHC4QlBu pic.twitter.com/mJnAsqGvGB

— New York Post (@nypost) October 8, 2020

U.S.A. アメリカ Vol.111（1st US Presidential Debate 9/29/2020 ― 米国大統領選挙テレビ討論会）

All the below tweets (@NewsHour, @CBSNews, @NBCPolitics, @ABCPolitics, @CNNPolitics) are in English.

Join @NewsHour for special coverage of the first presidential debate between Trump and Biden. https://t.co/tXqFDh8vlu

— PBS (@PBS) September 29, 2020

Though policy differences were largely lost in a near-constant flurry of interruptions, cross-talk and pleas for decorum by the moderator, Chris Wallace of Fox News, five themes emerged from the first presidential debate.https://t.co/qi7IIV2ffW

— PBS NewsHour (@NewsHour) September 30, 2020

Watch all the presidential debates since 1960 https://t.co/kTXDY9SJVg

— PBS NewsHour (@NewsHour) September 30, 2020

While Trump carried Ohio and Pennsylvania four years ago, he narrowly lost Minnesota, one of the few states he hopes to flip from blue to red this fall. https://t.co/UizTAr4XSk

— PBS NewsHour (@NewsHour) October 1, 2020

President Trump and former Vice President Joe Biden were back on the campaign trail Wednesday — and back to trading barbs. https://t.co/cIpLBcI7v9

— PBS NewsHour (@NewsHour) October 1, 2020

Were viewers actually able to learn anything about the candidates and their policies during the debate, or did the chaos overwhelm substance entirely? @danbalz and @sewellchan discuss. https://t.co/VAHodbZzP7

— PBS NewsHour (@NewsHour) October 1, 2020

Chris Wallace just broke a 12 year debate climate question drought #Debates2020 https://t.co/rkE3N2gBFG

— Kate Grumke (@KGrumke) September 30, 2020

How did the debate make voters who watched feel?
Far more felt annoyed than informed. pic.twitter.com/eJHiTS9oCT

— CBS News Poll (@CBSNewsPoll) September 30, 2020

Eight in 10 voters who watched tonight called the tone of the debate negative. pic.twitter.com/zvFnn5QmZy

— CBS News Poll (@CBSNewsPoll) September 30, 2020

CBS NEWS BATTLEGROUND TRACKER
Instant poll of debate watchers: more say Joe Biden won tonight’s debate pic.twitter.com/dHZqV95wqB

— CBS News Poll (@CBSNewsPoll) September 30, 2020

Several things the candidates said during last night's presidential debate were at least partially untrue.@PaulaReidCBS fact checks some of these claims, beginning with election integrity. #Debates2020 pic.twitter.com/5zDMK5R5KW

— CBS This Morning (@CBSThisMorning) September 30, 2020

CHAOS IN CLEVELAND: After a presidential debate full of insults and interruptions, the new debate over the future of debates is following what many are considering a new low in presidential politics.
@edokeefe breaks down what’s next for the campaigns. pic.twitter.com/3RIoDsYf84

— CBS Evening News (@CBSEveningNews) September 30, 2020

Watch the full first debate between President Trump and Joe Biden https://t.co/9K9Jm8JCkX

— CBS News (@CBSNews) September 30, 2020

How Americans responded to the first presidential debate of 2020 https://t.co/qBgrrykErH

— CBS News (@CBSNews) September 30, 2020

Many viewers were turned off by the negative tone of the first 2020 presidential debate between Trump and Biden

UVA Center for Politics Dir. Larry Sabato tells CBSN it was "the most incoherent" debate he's ever seen: "This will historically forever be the worst, I guarantee you" pic.twitter.com/G2YYAUgILc

— CBS News (@CBSNews) September 30, 2020

Trump encourages supporters to independently monitor polling places — a federal crime https://t.co/uATFyZLFnW

— CBS News (@CBSNews) September 30, 2020

Debate-watchers say Biden won first debate, but most felt "annoyed" – CBS News poll https://t.co/4hlkiDxaHt

— CBS News (@CBSNews) September 30, 2020

Biden: "Millionaires and billionaires like [Trump], in the middle of the COVID crisis, have done very well…You folks at home, you folks living in Scranton and Claymont and all the small towns and working-class towns in America, how well are you doing?" https://t.co/XoIMrd5i2b pic.twitter.com/Nxbqy3IIg1

— CBS News (@CBSNews) September 30, 2020

Trump says he wears masks "when needed" and mocks Biden's masks https://t.co/a8L1hkM6s8

— CBS News (@CBSNews) September 30, 2020

Fact check: Did Obama have the "slowest recovery" since 1929? #PresidentialDebate2020 https://t.co/bdNbtqqd5b pic.twitter.com/5vokVSZduN

— CBS News (@CBSNews) September 30, 2020

.@PhilippeReines played Donald Trump for Hillary Clinton's debate prep in 2016. He tells CBSN the best strategy for debating Trump is staying out of his way and letting him make his own errors: "The guy never misses an opportunity to miss an opportunity" https://t.co/XoIMrd5i2b pic.twitter.com/gVNgAEA7XO

— CBS News (@CBSNews) September 30, 2020

Biden's message to Proud Boys is "cease and desist" and Trump tries to clean up his comments https://t.co/sMZLCojR1t

— CBS News (@CBSNews) September 30, 2020

NEW: After chaotic first debate, Commission on Presidential Debates says changes coming to format for remaining two https://t.co/wGXcsgsr4g

— CBS News (@CBSNews) September 30, 2020

The presidential election is just 34 days away. With millions expected to vote by mail this year, it’s more important than ever to know when, where and how to cast your ballot for your state. #AmericaDecides https://t.co/FiJUqUsUDT pic.twitter.com/wV6qrzcSyh

— CBS News (@CBSNews) September 30, 2020

Obama accuses Trump administration of working to keep "communities of color" from voting in new ad https://t.co/k7IQ9fSUJn

— CBS News (@CBSNews) September 30, 2020

Biden uses Arabic phrase "Inshallah" to mock Trump over his tax returns during debate https://t.co/h2xfMedJgo

— CBS News (@CBSNews) September 30, 2020

Biden campaign raises record $3.8 million in second hour of debate https://t.co/YE6TFhRh0j

— CBS News (@CBSNews) September 30, 2020

WATCH LIVE: Joe Biden speaks at campaign event in Ohio https://t.co/Nj065CIsxp https://t.co/6tUx0Pivtu

— CBS News (@CBSNews) September 30, 2020

Democrats put Obamacare center stage in Supreme Court confirmation battle https://t.co/4bVEeEqJng

— CBS News (@CBSNews) September 30, 2020

Who will stay on topic? We're tracking the candidates during tonight's presidential debate. Follow along here https://t.co/fWaPbP0Yz4 pic.twitter.com/LMmWQ4xbDq

— NBC News Graphics (@NBCNewsGraphics) September 30, 2020

“Under this president we’ve become weaker, sicker, poorer, more divided and more violent.” –@JoeBiden #Debates2020 pic.twitter.com/Umv2sNJwGn

— TODAY (@TODAYshow) September 30, 2020

WATCH: After more than an hour and a half of the first presidential debate, @chucktodd says, "It was a train wreck."

"I don't know how that helped anybody" #debates2020 pic.twitter.com/ZrUjSbPnyW

— Meet the Press (@MeetThePress) September 30, 2020

LIVE: The first presidential debate between President Donald Trump and former VP Joe Biden. #Debates2020 https://t.co/SZPNLjzyXj

— NBC Politics (@NBCPolitics) September 30, 2020

A Biden adviser said that if President Trump’s strategy was to drive a wedge between Biden and progressives, it only backfired. https://t.co/fSY9pN5EXg

— NBC Politics (@NBCPolitics) October 1, 2020

BREAKING: Commission on Presidential Debates: "Last night’s debate made clear that additional structure should be added to the format of the remaining debates to ensure a more orderly discussion of the issues." https://t.co/Lwb5aOgUuZ

— NBC Politics (@NBCPolitics) September 30, 2020

Analysis: President Trump’s fear dominated his first debate with Joe Biden. https://t.co/xDSM9x2UoF – @jonallendc

— NBC Politics (@NBCPolitics) September 30, 2020

WATCH: While speaking about President Trump's tax records, Joe Biden vowed to eliminate the Trump admin.'s tax cuts and called Trump the "worst president America has ever had."https://t.co/fHNez4amw2

— NBC Politics (@NBCPolitics) September 30, 2020

4 takeaways from the first debate between President Trump and Joe Biden https://t.co/Xcrnuo2LBJ

— NBC Politics (@NBCPolitics) September 30, 2020

President Trump launched into a lengthy and falsehood-riddled diatribe about mail voting at the tail-end of the first presidential debate.

Here are his claims, and the facts. https://t.co/lPC6xRtzwR

— NBC Politics (@NBCPolitics) September 30, 2020

To little effect, Chris Wallace tried to put the brakes on President Trump's frequent interruptions in tonight's debate. https://t.co/EeQTu69pOy

— NBC Politics (@NBCPolitics) September 30, 2020

PLAN YOUR VOTE: This guide from @NBCNews helps you know deadlines to vote, eligibility to vote by mail and more, based on the rules of your state. https://t.co/5gKqMRurdb #PlanYourVote #Debates2020

— NBC Politics (@NBCPolitics) September 30, 2020

Ahead of tonight's debate, Joe Biden tweets photo mocking Trump debate conspiracy theories about an earpiece and performance enhancements. https://t.co/M0ZPc2AGzw

— NBC Politics (@NBCPolitics) September 30, 2020

.@LesterHoltNBC will anchor a live town hall discussion with Democratic presidential nominee Joe Biden on Monday, Oct. 5, from Miami. https://t.co/rLnmRdPplt

— NBC Politics (@NBCPolitics) September 30, 2020

"We've taken more refugees in the United States than any other nation over the course of the last 20 years," Sec. Pompeo says in defense of the Trump admin.'s record on human rights in China. https://t.co/hlYeZBn2dY

— NBC Politics (@NBCPolitics) October 1, 2020

Tuesday night’s 10-minute discussion on climate change was the most that the topic has been discussed in a presidential debate since 1988. https://t.co/Pi8zdcBrw4

— NBC Politics (@NBCPolitics) September 30, 2020

　https://twitter.com/NBCPolitics/status/1311440956495888384

DEBATE PREVIEW: Joe Biden enters as the clear front-runner in the race. The one big issue that Donald Trump beats him on is the economy — and it represents his best chance to close the gap. If he fails to exploit that advantage, or loses it, it's over. https://t.co/DcteL0jhRR

— Sahil Kapur (@sahilkapur) September 30, 2020

Hillary Clinton: "Donald Trump is a clear and present danger to the national security of our country. He has demonstrated repeatedly that his first allegiance is not to the United States of America." #MSNBC2020 pic.twitter.com/DMYecbRqiE

— MSNBC (@MSNBC) September 30, 2020

Our 2020 Election Forecast: https://t.co/avpe1Jp1GC

— FiveThirtyEight (@FiveThirtyEight) September 30, 2020

How Americans view the coronavirus crisis and Trump's response: https://t.co/f4EvOoYUOC

— FiveThirtyEight (@FiveThirtyEight) September 30, 2020

South Carolina (Trump +6.6) and Alaska (Trump +4.4) now polling closer than Michigan (Biden +6.9) and Wisconsin (Biden +6.8). https://t.co/UsJEKmHCAW pic.twitter.com/PTx5Gos9jr

— Nate Silver (@NateSilver538) September 30, 2020

Pres. Trump: "We have to go back to the core values of our country."

Joe Biden: "He's the racist."

WATCH LIVE: https://t.co/fWneV8WJet #Debates2020 pic.twitter.com/b1tEuFfDO8

— Good Morning America (@GMA) September 30, 2020

President Trump falsely claimed Tuesday night that "poll watchers" were blocked from entering voting locations in Philadelphia, bringing back to the forefront the legal battle his campaign and the RNC have been waging in Pennsylvania since late June. https://t.co/NsqG8ikrpY

— ABC News Politics (@ABCPolitics) October 1, 2020

JUST IN: The Commission on Presidential Debates said it will consider 'structure' changes after Tuesday night's chaotic debate. https://t.co/6vRHxBDsw9

— ABC News Politics (@ABCPolitics) September 30, 2020

The first debate pitting Republican President Donald Trump against Democratic challenger Joe Biden was not a highlight of political oratory in the eyes of many overseas. https://t.co/XSQADf3cGL

— ABC News Politics (@ABCPolitics) September 30, 2020

Joe Biden is embarking on a roughly 200-mile train tour today through Ohio and Pennsylvania, appealing to voters who have strayed from Democrats in recent years. https://t.co/TvRbiuUkbQ

— ABC News Politics (@ABCPolitics) September 30, 2020

Sen. Bernie Sanders expresses disappointment in the first presidential debate between President Donald Trump and Democratic nominee Joe Biden, describing it as "not one of the great moments in American history." https://t.co/iQYn2tbbRw

— ABC News Politics (@ABCPolitics) September 30, 2020

The first point of clarity, despite the president's efforts to cast vote-by-mail as riddled with fraud, is that it's a safe and secure option. https://t.co/2jFTYAg66o

— ABC News Politics (@ABCPolitics) September 30, 2020

President Donald Trump unfurled a wide range of false and misleading claims about the realities of voting in this country — voting that, of course, has already begun. https://t.co/0gupIQ6QLU

— ABC News Politics (@ABCPolitics) September 30, 2020

Chaos of 1st presidential debate prompts reactions of dismay, disappointment. https://t.co/FHI2RuNrqd

— ABC News Politics (@ABCPolitics) September 30, 2020

"It may be that the debate is declared a draw – or a double loss, since so little light was generated among all that heat," @rickklein writes.

ANALYSIS: Trump and Biden show their own vulnerabilities in a messy argument that was barely a debate: https://t.co/llKMgr4WGz

— ABC News Politics (@ABCPolitics) September 30, 2020

Squabbling leads to incoherence, leaving key questions unanswered for the American people.

5 takeaways from the first presidential debate: https://t.co/v6ARigypsR #Debates2020

— ABC News Politics (@ABCPolitics) September 30, 2020

"I don't support the Green New Deal," Joe Biden says. "I support the Biden plan." https://t.co/qRMoWiBWGD #Debates2020 pic.twitter.com/OuUOVFRaCC

— ABC News Politics (@ABCPolitics) September 30, 2020

Fact-checking Trump and Biden https://t.co/X7mBkAQyQ6 #Debates2020

— ABC News Politics (@ABCPolitics) September 30, 2020

Most Americans are skeptical of Pres. Trump's performance on the COVID pandemic, disbelieving of his rhetoric on the virus and critical of what they view as his lagging approach to containing it, a recent @ABC News/Ipsos poll found. https://t.co/5icIcIce1M

— ABC News Politics (@ABCPolitics) September 30, 2020

Although many people are concerned about the safety of in-person voting during the COVID-19 pandemic, public health experts say that with the proper precautions, risks can be minimized. https://t.co/IfJGtcQlJh

— ABC News Politics (@ABCPolitics) September 30, 2020

　https://twitter.com/ABCPolitics/status/1311146510810255360

“President Trump clearly has control issues. He couldn’t stop his anger.”

“It was like watching my own children having a disagreement at home.”

Undecided Ohio voters discuss the first presidential debate with @AnaCabrera https://t.co/J1SNjZHRX2 pic.twitter.com/jfa2YrJRSL

— New Day (@NewDay) September 30, 2020

10 false or misleading claims Joe Biden and Donald Trump make about each other https://t.co/JES8n3EdQn pic.twitter.com/L7aNrswYYE

— CNN Politics (@CNNPolitics) September 30, 2020

President Trump's chaotic debate underscores the stakes of November's election | Analysis https://t.co/GuxIp2oa9g pic.twitter.com/a4437YJGLp

— CNN Politics (@CNNPolitics) September 30, 2020

CNN's @ddale8 says while Joe Biden was "largely accurate" during tonight's presidential debate, "we had an avalanche of lying from President Trump."

He says at points during the debate, "almost every single thing (Trump) said … was inaccurate" #Debates2020 pic.twitter.com/yra0mWnAHy

— CNN Politics (@CNNPolitics) September 30, 2020

President Trump is controlling tonight's debate — that doesn't mean he's winning it | Analysis #Debates2020 https://t.co/mEGcTVRcBo

— CNN Politics (@CNNPolitics) September 30, 2020

Only 20 minutes into the first presidential debate, and it's chaos https://t.co/e3AVqvvuQD pic.twitter.com/X2DJMsHRIJ

— CNN Politics (@CNNPolitics) September 30, 2020

How do you distinguish a good poll from a bad poll? @ForecasterEnten breaks it down in the newest episode of #Election101. Listen here: https://t.co/H5vtlgV55f

— CNN Politics (@CNNPolitics) September 30, 2020

Federal judge refuses to stop mail-in voting in Montana, blasts Trump-backed "fiction" of massive voter fraud https://t.co/2ZqI7wCWd2 pic.twitter.com/FxPkL3Lh9o

— CNN Politics (@CNNPolitics) September 30, 2020

　https://twitter.com/CNNPolitics/status/1311209182851485696

U.S.A. アメリカ Vol.107（New York ニューヨーク州 Vol.2: pharmaceutical corporations 製薬会社）

All the below links and tweets are in English.

取り急ぎ以下貼っておきます。
New York Vol.35 (corporations: Pfizer)
New York Vol.36 (corporations: Bristol Myers Squibb)
New York Vol.37 (corporations: Regeneron)

ツイッター検索で上記3製薬会社各社及び Japan や日本の5製薬会社各社名を入れて出て来たもの

AFIB awareness month – learn more here and spread the word. #Bayer #Daiichi-Sankyo #BMS #Pfizer https://t.co/v8seSL6y3u

— Medable (@medableinc) September 24, 2020

#XTANDI #news
Pfizer and Astellas announced the final results of the overall analysis from Phase 3 PROSPER study#asco20 #asco2020 #oncology #pharmanews #pfizer #astellas #conferences #consultingservices https://t.co/Tj2z4xc0rn

— ipharmacenter (@ipharmacenter) May 30, 2020

Insights on the Worldwide Antihypertensive Drugs Industry to 2026 – Players Include Pfizer, Takeda Pharmaceutical & AstraZeneca Among Others – https://t.co/8vPVgQlQhj https://t.co/bzOL6dTM2O

— Pharmacutical Daily (@PharmacDaily) April 6, 2020

Pfizer, Astellas' Xtandi scores Bayer-matching win in extending prostate cancer patients' lives. Can Pfizer and Astellas leverage this data into building Xtandi as the market leader in castration-resistant #prostatecancer? #pcsm $PFE https://t.co/r6Qu9NOoll pic.twitter.com/8EiTRmgIxE

— Bionest Partners (@BionestPartners) February 12, 2020

FDA approves expanded label for Pfizer, Astellas' prostate cancer therapy Xtandi https://t.co/fCFTjO9ita

— Stuart Edmonds (@stuartd_e) December 19, 2019

Great turnout for our Siemens Sitrain TIA Portal Service 1 course. Patrick Martin from Siemens SITRAIN Manchester @siemensuknews was the trainer & participants came from #EirGen, #Pfizer, #Takeda & #IMALife. The course will run again in Feb '20: https://t.co/8uD3AVwAWq(tia-s.aspx pic.twitter.com/2FETEXmR6E

— Engineers Ireland (@EngineerIreland) December 5, 2019

ImaginAb joins with AZ, Pfizer and Takeda to develop tumour imaging tech, writes @pharmaphorum https://t.co/ZBtv9FxFG3

— ImaginAbInc (@ImaginAbInc) October 14, 2019

Pfizer, Astellas win priority review for Xtandi sNDA; Hemispherx changes its name https://t.co/p50wHHb5X1 $PFE

— Endpoints News (@endpts) August 24, 2019

Parenteral Nutrition Market 2019: Industry Analysis and Detailed Profiles of Top Industry Players B. Braun Melsungen AG, Fresenius Kabi AG, ALLERGAN, Grifols, S.A., Pfizer Inc., Otsuka Pharmaceutica https://t.co/Asz3gkZp3s pic.twitter.com/NfOrepvOzK

— PressRelease.cc (@PressRelease_cc) May 21, 2019

See how #Pfizer, #AstraZeneca, #Sanofi, #Astellas and more are achieving real patient centric processes in these free panels from our 2019 patient track https://t.co/RYUehW8IOL

— Reuters Events Pharma (@RE_Pharma) October 11, 2019

@pfizer or Otsuka. Which company do you admire the most? Vote here: https://t.co/2YWu39L6xM #mostadmiredpharma pic.twitter.com/WKI5AzT7pR

— Reuters Events Pharma (@RE_Pharma) January 10, 2017

#Pfizer, #Astellas’ #Xtandi significantly improves #OS in phase 3 #prostatecancer study https://t.co/Sl5SywJbvp via @Pharma_BR @pfizer @AstellasUS @pfizer_news

— Plexus Ventures (@PlexusVentures) February 13, 2020

Pfizer, Astellas' Xtandi scores Bayer-matching win in extending prostate cancer patients' lives https://t.co/6Cf4Ow9STS

— FiercePharma (@FiercePharma) February 11, 2020

J&J's Erleada scores metastatic prostate cancer nod in battle with Pfizer-Astellas' Xtandi https://t.co/Eig4GG22N9

— FiercePharma (@FiercePharma) September 18, 2019

Pfizer, Astellas rocket toward broader Xtandi use with FDA 'priority' tag https://t.co/KcOPOyolpw

— FiercePharma (@FiercePharma) August 22, 2019

Pfizer, Astellas chase new Xtandi nod with big survival numbers in prostate cancer https://t.co/x2nz46FY1l

— FiercePharma (@FiercePharma) February 12, 2019

The deals with Novartis, Otsuka, Pfizer and Sanofi will boost its ecosystem and “could help foster greater scientific discovery” as the pharma companies work on “next-generation research and development programs,” Verily said: https://t.co/h6tD7yJiaf

— FierceBiotech (@FierceBiotech) May 21, 2019

Prostate cancer shake-up looms with new data from Pfizer, Astellas and Johnson … https://t.co/reOTWifrUC $JNJ #stocks #stockmarket

— StockMarketScoop (@StockScoops) February 26, 2019

Japan has signed a deal to secure 120 million doses of a potential coronavirus vaccine, German pharmaceutical group BioNTech, which is developing the drug with US pharma giant Pfizer, said. https://t.co/crihB500gj

— Philstar.com (@PhilstarNews) August 1, 2020

More updates to @nytimes vaccine tracker: Sanofi makes a deal to supply US with protein vaccines, Pfizer makes a deal with Japan, Vaxine finishes Phase I trials, and monkeys get protection from Moderna and J&J shots. https://t.co/8RbPgaLziS

— Carl Zimmer (@carlzimmer) July 31, 2020

Pfizer, BioNTech to supply 120 million doses of coronavirus vaccine to Japan https://t.co/CPE5UL5WWR pic.twitter.com/iphKs1StYM

— Reuters (@Reuters) July 31, 2020

Pfizer Japan recalls high blood pressure drug over cancer-causing impurity https://t.co/9LdUeUtJi0 pic.twitter.com/mo0igvh0Hb

— Reuters (@Reuters) February 8, 2019

Pfizer Japan recalls its high blood pressure drug Amvalo containing the API valsartan after possible carcinogenic impurities were found. https://t.co/g7iIuIf8Wl

— ConsumerSafetyWatch (@consumersafetyw) February 11, 2019

Pfizer Japan drawn into valsartan recall after finding API from Mylan is tainted #Pharma https://t.co/6bR5IJSo4L

— Varadharajan K PhD (@VaradhKrish) February 13, 2019

Pfizer Japan Cautious Over New Policies As Sales Slip https://t.co/WCU1uOPqqO

— Ian Haydock (@ScripIanHaydock) March 2, 2018

Pfizer expands Japan contracting offering touting market knowhow https://t.co/5WwiesSuTE #onmedic #ehealth #pharma

— onmedic global (@onmedicglobal) October 23, 2017

From the Pfizer Photo Archives: A sales rep discusses medicines with a pharmacist in Nagoya, #Japan (1967) pic.twitter.com/b864XJQgSq

— Pfizer Inc. (@pfizer) March 5, 2016

From the Pfizer Photo Archives: Sales reps at Pfizer #Japan prepare for a busy day of appointments (1963) pic.twitter.com/lCLRWnW3wc

— Pfizer Inc. (@pfizer) February 6, 2016

Pfizer Japan matches PFE colleague donations to fund recovery efforts from devastating #NepalEarthquake pic.twitter.com/HoRjVNyJ0W

— Pfizer Inc. (@pfizer) August 21, 2015

Anti-Obesity Prescription Drugs Market Future Scenario, CAGR, Key Developments and Size|Bristol-Myers Squibb Co., Takeda Pharmaceutical., Eisai Company.https://t.co/UqYXeQUzeB #news #pharma #pharmiweb

— Pharma News (@pharminews) September 22, 2020

Bristol-Myers Squibb, Takeda and Daiichi Sankyo shot up rankings of top 20 pharma companies by market cap, according to a new GlobalData analysis https://t.co/EJc7SrNBnM

— pharmaphorum (@pharmaphorum) June 22, 2020

MedNess this week features bite size news on:

BioMarin’s hemophilia A candidate accepted for FDA priority review

Japan Approves Bristol-Myers Squibb's Opdivo for Esophageal Cancer

FDA Issues Complete Response Letter for sBLAs…https://t.co/oLDevWice6 https://t.co/AYfj4HBTeX

— Ananda Ghosh, PhD (@andz79) February 26, 2020

Professionals from Becton Dickinson, Astellas, Novartis, Bristol-Myers Squibb, and more convene at Novo Nordisk headquarters for the upcoming 15th Public Relations & Communications Summit. https://t.co/pCJ7YBFjlF

— Fierce Life Sciences Events (@LifeSciEvents) April 30, 2019

Roche says 'no thanks' to megadeals, but don't count out smaller M&A: After two recent, huge tie-ups between Takeda and Shire and Bristol-Myers Squibb and Celgene, megamergers seem to be a biopharma trend. But Roche isn't interested, its chairman said. https://t.co/BAAOw2Wgks

— cafepharma (@cafepharma) January 22, 2019

Taisho Pharmaceutical will acquire the French over-the-counter drugmaker UPSA from Bristol-Myers Squibb, the latest move by Japan's top seller of nonprescription medicines to expand overseas. https://t.co/hDgtCvt9Xr

— Nikkei Asian Review (@NAR) December 19, 2018

Immunosuppressants Market Impressive Growth 2019 | GlaxoSmithKline plc, Novartis AG, Sanofi, Bristol-Myers Squibb Company, Pfizer Inc., Astellas Pharma Inc., Zydus Cadila https://t.co/UgRU3aWvgK pic.twitter.com/zRdA3OAcP7

— ABNewswire (@ABNewswire) September 13, 2019

Thymus Cancer Market to Grow exponential with Astellas Pharma | Astrazeneca | Bristol-Myers Squibb | Takeda pharmaceutical company, etc. – Asserts MRFR Unleashing Industry Forecast to 2024 https://t.co/j0Lby60IiK pic.twitter.com/t40OOZcXlh

— ABNewswire (@ABNewswire) May 9, 2018

Bristol-Myers Squibb Granted Exclusive License by Ono Pharmaceutical for Multiple Programs Targeting Immuno-Suppressive Factors in the Tumor Microenvironment: PRINCETON, N.J. & OSAKA, Japan–(BUSINESS WIRE)–$BMY–Bristol-Myers Squibb Granted Exclusive… https://t.co/tDraaRo0Yy pic.twitter.com/FZjSnGbDS1

— Business Wire-Health (@BW_Health) December 13, 2017

Bristol-Myers Squibb and Otsuka Pharmaceutical have reached a global settlement with plaintiffs in multidistrict litigation over side effects of their antipsychotic drug Abilify. https://t.co/Cxi3FktGho pic.twitter.com/pNGBz0wMFy

— Law360 (@Law360) February 26, 2019

Bristol-Myers Squibb, Daiichi Sankyo to Jointly Test Opdivo/DS-8201 Combo in HER2+… https://t.co/cnBZiI9qa3 pic.twitter.com/M95ccszHnv

— Immuno-Oncology News (@immunooncnews) September 5, 2017

Bristol-Myers Squibb starts research collaboration with Eisai – https://t.co/iKI2PJKO1q pic.twitter.com/m5oXPiRSCQ

— GMPnews.Net (@GMPnewsNet) December 17, 2018

https://twitter.com/UMCGlobalSafety/status/1180090377161908224

8-25-2020: Starting 4 months from now, Lilly's LY-CoV555, Regeneron's REGN-COV2, AstraZeneca's AZD7442, or Takeda/Behring/Octapharma might work for early COVID-19, be expensive, be vulnerable to mutations, and be in short supply:https://t.co/s29UYtb9o3 https://t.co/ijHm26afc3

— Ronald M. Chavin (@rmchavin) August 25, 2020

Adimab broadens R&D deals with Novartis, Regeneron, Takedahttps://t.co/9gF1SqcuEq #R&D #novartis #regeneron #takeda #health #healthcare #pharmaceutical #digitalhealth #vitalyhealth

— Vitaly Health (@HealthVitaly) May 19, 2019

Adimab broadens R&D deals with Novartis, Regeneron, Takeda https://t.co/PLAwHC7tjz career medical device pic.twitter.com/cbGNbtODv1

— ThinKeen Global (@thinkeenglobal) May 8, 2019

Takeda and Regeneron continue to tap into Adimab’s capabilities https://t.co/lIicDWO57S pic.twitter.com/bUbVGC5pmH

— JackLeckerman (@JackLeckerman) May 13, 2019

“Regeneron (REGN) Reports Approval of DUPIXENT in Japan for Treatment of Atopic Dermatitis” https://t.co/kUdtuobA6v pic.twitter.com/2YRe5IDgEO

— Juan C Ivancevich MD (@Aller_MD) January 22, 2018

13 co's working on Coronavirus treatments/vaccines. Gilead's remdesivir is in late stage testing, GlaxoSmithKline is collaborating with Britain, U of Queensland. See also, Heat Biologics, Inovio, Johnson & Johnson, Moderna, Regeneron, Sanofi, Takeda, more. https://t.co/NyT4jixMES

— Dori Smith (@Dori_TalkNation) March 17, 2020

Biopharma's ever-evolving #COVID19 response, distilled:

Gilead, AbbVie, Pfizer looking at antivirals
J&J, Sanofi, and Moderna on vaccines
Regeneron, Eli Lilly, and Vir on antibodies
Takeda and Emergent on plasma therapyhttps://t.co/8S4Ucbc6ef

— Andrew Dunn (@AndrewE_Dunn) March 13, 2020

Recent articles about Japan 日本関連英文記事 Vol.2

All the below tweets are in English.

Japan's economy minister instructed by new PM to take steps without hesitation https://t.co/SiCJ1ZTnFU pic.twitter.com/lFsQdM8851

— Reuters (@Reuters) September 17, 2020

Japan's reappointed finance minister Aso says will prod regional banks to pursue reforms https://t.co/WAZp0v2BNV pic.twitter.com/4WuhopXYo3

— Reuters (@Reuters) September 17, 2020

BOJ to hold fire, signal resolve to work closely with Suga's new cabinet https://t.co/yqw5rAjbSZ pic.twitter.com/dTr8OriSFV

— Reuters (@Reuters) September 17, 2020

Japan's longest-serving prime minister Shinzo Abe left office amid applause before his longtime aide Yoshihide Suga was voted prime minister by parliament https://t.co/hKCJX4sWIZ pic.twitter.com/VYrTnrLJJp

— Reuters (@Reuters) September 16, 2020

Japan’s new Prime Minister Yoshihide Suga said he would stick with his former boss’ 'Abenomics' growth policies while pushing reforms https://t.co/PFUWnSF9bC pic.twitter.com/4tlbtLOFFM

— Reuters (@Reuters) September 16, 2020

From @Breakingviews: Japan has a new prime minister after nearly eight years. Yoshihide Suga, the tight-lipped technocrat, will need to shed some of his stern demeanor to lead the country out of recession, says @petesweeneypro pic.twitter.com/eWji7cC9sE

— Reuters (@Reuters) September 16, 2020

Telefonica partners with Japan's Rakuten to develop open 5G network https://t.co/FQtFzQyIMf pic.twitter.com/BNsFRXUpkh

— Reuters (@Reuters) September 16, 2020

China says it hopes Japan will not develop official ties with Taiwan https://t.co/S8aWZPP07W pic.twitter.com/IxK1g8HGVh

— Reuters (@Reuters) September 16, 2020

Japan’s Yoshihide Suga was voted prime minister by parliament to become the country’s first new leader in nearly eight years, appointing a new cabinet that kept about half of the familiar faces from predecessor Shinzo Abe’s lineup https://t.co/e9YG3w6TL6

— Reuters (@Reuters) September 16, 2020

Japan's exports extend double-digit declines as pandemic hits demand https://t.co/e3kNHS0rOJ pic.twitter.com/wJKcX7OBE1

— Reuters (@Reuters) September 16, 2020

Japan defence minister Kono to become internal affairs min in new cabinet: Kyodo https://t.co/PH4IqpQmUo pic.twitter.com/C75zhyYPEc

— Reuters (@Reuters) September 15, 2020

After sweeping party poll, Japan's Suga faces tricky call on snap election https://t.co/hXKdA0zFZb pic.twitter.com/yYvm4vUcQP

— Reuters (@Reuters) September 15, 2020

Japan's Aso says should consider early dissolution of parliament https://t.co/PI5GGsIn5T pic.twitter.com/0UQwnnEols

— Reuters (@Reuters) September 15, 2020

Japan's new leadership agenda could make jobs a bigger BOJ priority https://t.co/jfL67MCYVv pic.twitter.com/DjgE1y38Dv

— Reuters (@Reuters) September 15, 2020

Japan ruling party head Suga preparing cabinet, continuity in foreground https://t.co/4WcznGiSY5 pic.twitter.com/2FJqlXeXJ1

— Reuters (@Reuters) September 15, 2020

Japan health minister Kato likely to replace Suga as chief cabinet secretary: Nippon TV https://t.co/ErdsJudoE6 pic.twitter.com/LDsrJGTs6n

— Reuters (@Reuters) September 15, 2020

From @Breakingviews: Nvidia will buy UK-based chip designer Arm from Japan’s SoftBank Group and its growth will depend on winning over many of Arm’s customers like Intel, which compete with Nvidia, as well as anti-trust regulators around the world, @LiamWardProud says pic.twitter.com/kmcEjAooNu

— Reuters (@Reuters) September 15, 2020

United Airlines to close Japan's Narita hub, affecting 270 jobs: NHK https://t.co/OqmpLBQHfu pic.twitter.com/x2n3OOKtWU

— Reuters (@Reuters) September 14, 2020

Japan's Suga wins ruling party leadership race to replace Abe https://t.co/zs7oL16itL pic.twitter.com/zsSHbVTY38

— Reuters (@Reuters) September 14, 2020

Japan’s Yoshihide Suga wins ruling party leadership election, paving the way for him to become prime minister in a parliamentary vote this week https://t.co/YRwm9K9Int pic.twitter.com/3v3Mf1JIOr

— Reuters (@Reuters) September 14, 2020

Japan's next prime minister as a boy: good in sports, 'stiff' as actor https://t.co/92zlCQfyYQ pic.twitter.com/3UKmjxhTkO

— Reuters (@Reuters) September 14, 2020

Factbox: Japan next premier's hometown: demographic challenges by the numbers https://t.co/1QTxKQCVxG pic.twitter.com/uYzx0b55Te

— Reuters (@Reuters) September 14, 2020

Japan's Suga says no limit to bonds government can issue https://t.co/3UiYqHO5yH pic.twitter.com/pMLXlXn8Aa

— Reuters (@Reuters) September 13, 2020

Japan's Suga says no limit to bonds government can issue https://t.co/47gMZ8iSS1 pic.twitter.com/1Z6Zr4GW3H

— Reuters (@Reuters) September 13, 2020

Osaka 'a Jesse Owens of Japan' for racial injustice stand https://t.co/imj7cYQq6T pic.twitter.com/sz0sVBx8j1

— Reuters (@Reuters) September 12, 2020

Hip hop hooray for Japan's next PM with hometown T-shirt shout-out https://t.co/AoHablSyRd pic.twitter.com/PDxTZiwS7N

— Reuters (@Reuters) September 12, 2020

Japan's Suga, likely next PM, says ready to top up payouts to ease COVID-19 pain https://t.co/3I5JpaJRM1 pic.twitter.com/271DkXf312

— Reuters (@Reuters) September 12, 2020

Japan's Suga seeks solid communications with Asian neighbors https://t.co/dTL3DCFEJK pic.twitter.com/1iEUL3WkjB

— Reuters (@Reuters) September 12, 2020

Tiffany gets regulatory nod from Japan, Mexico for troubled LVMH deal https://t.co/VqNr9haIIm pic.twitter.com/Dn4jrGvVPh

— Reuters (@Reuters) September 11, 2020

Abe plan for land-attack counterpunch could mark major military shift for Japan https://t.co/N3f7XG0xhq pic.twitter.com/CFgEMjmg4A

— Reuters (@Reuters) September 11, 2020

UK and Japan strike Britain's first post-Brexit trade deal https://t.co/KTn04NK77g pic.twitter.com/BxaqsrdWbx

— Reuters (@Reuters) September 11, 2020

Japan's new government should focus on response to coronavirus, digitalization: Reuters poll https://t.co/1rmBToSQ86 pic.twitter.com/2PacSUBneb

— Reuters (@Reuters) September 11, 2020

Japan foreign minister says aims to reach broad agreement on UK trade deal Friday https://t.co/lIXpIorFrb pic.twitter.com/BvA9E7BOZl

— Reuters (@Reuters) September 11, 2020

Japan firms plan to cut capex by 6.8% this fiscal year: survey https://t.co/cjgobzhKJO pic.twitter.com/yQzvX3gUgg

— Reuters (@Reuters) September 11, 2020

Japan's Suga: Will have to call for sales tax hike in future https://t.co/4P8FLYxHCw pic.twitter.com/SRlShwBXgo

— Reuters (@Reuters) September 10, 2020

Stuck at home for weeks while Japan was under a state of emergency due to the coronavirus, renowned Japanese Bunraku puppet master Kanjuro Kiritake, all his performances canceled for months, was stricken with deep anxiety https://t.co/ITent24Oip

— Reuters (@Reuters) September 10, 2020

Yoshihide Suga, on course to become Japan’s next prime minister, said he would maintain incumbent premier Shinzo Abe’s policy prioritizing economic growth over efforts to fix the country’s tattered finances https://t.co/n0731rDKOc

— Reuters (@Reuters) September 9, 2020

Exclusive: Japan ruling coalition partner Komeito indicates it does not want snap election https://t.co/oEcSPCorwu pic.twitter.com/fuompQDij9

— Reuters (@Reuters) September 9, 2020

Japan's households, firms keep hoarding cash at record pace as COVID-19 strains broaden https://t.co/rLbJKNkW0A pic.twitter.com/pLs5P2Re3o

— Reuters (@Reuters) September 9, 2020

Japan's Suga in pole position for PM as debate kicks off https://t.co/AWXlIX2ibM pic.twitter.com/H5UMOlUlFr

— Reuters (@Reuters) September 9, 2020

Japan's Suga says important to cover fertility treatment by national insurance https://t.co/8xeoz2tlgy pic.twitter.com/8XDyhPHQJa

— Reuters (@Reuters) September 9, 2020

Japan’s economy shrank by over 28% in the second quarter as the global crisis had businesses struggling more than initially thought, underscoring the daunting task the new prime minister faces in averting a steeper recession https://t.co/WGdKT6Sbrd pic.twitter.com/fi2eOCJQ2X

— Reuters (@Reuters) September 8, 2020

Japan's Chief Cabinet Secretary Yoshihide Suga, a frontrunner to succeed Prime Minister Shinzo Abe, could call a snap election to solidify his political grip if he becomes the country's next premier https://t.co/mN5FBhmnnE pic.twitter.com/pH5vQRfS81

— Reuters (@Reuters) September 8, 2020

Tokyo 2020 Olympics organisers have not extended sponsors’ contracts set to expire at the end of the year, sources said, leaving some questioning whether to continue after COVID-19 forced a delay of the world’s largest sporting event https://t.co/e51BZ3IRaD

— Reuters (@Reuters) September 8, 2020

Factbox: Continuity and reforms: Japan PM hopeful Suga's key policies https://t.co/Gr20nDT77C pic.twitter.com/NXxZB5a5tP

— Reuters (@Reuters) September 8, 2020

Japan defence chief Kono expects to be prime minister one day, but backs Suga to succeed Abe https://t.co/DD2zcP0akQ pic.twitter.com/UtWRxXKs1T

— Reuters (@Reuters) September 3, 2020

Japan LDP heavyweight Kishida: Frank discussions needed with U.S. over defence burden https://t.co/7Hq6jQl89v pic.twitter.com/bgteKbqja5

— Reuters (@Reuters) September 2, 2020

Japan former foreign minister Kishida announces candidacy to succeed PM Abe https://t.co/KAJ37IIfMb pic.twitter.com/qMr56YBcHi

— Reuters (@Reuters) September 1, 2020

Japan's PM candidate Kishida cautious about cutting sales tax https://t.co/c2rpGAR3j5 pic.twitter.com/eQ4ijGJ9LI

— Reuters (@Reuters) August 31, 2020

Japan Defence Minister Kono says still undecided on run for ruling party leadership https://t.co/RIOCsS4eR8 pic.twitter.com/mL7SYNzqWs

— Reuters (@Reuters) September 1, 2020

Ex-defence minister Ishiba is people's choice for next Japan PM: polls https://t.co/vz2wwRC27L pic.twitter.com/FDUz78EpgK

— Reuters (@Reuters) August 31, 2020

Japan's Koizumi won't seek to succeed Abe as PM, would back Kono – NHK https://t.co/qkqUEYeUkN pic.twitter.com/sD38jEwhIV

— Reuters (@Reuters) August 30, 2020

Japan’s Sumitomo Corp. exits U.S. shale gas industry. via @Reuters https://t.co/wowqaMYt5d

— IEEFA_AsiaPacific (@IEEFA_AsiaPac) September 10, 2020

BREAKING: Yoshihide Suga has been formally elected Japan’s prime minister in a parliamentary vote. Suga was long the right-hand man to his predecessor, Shinzo Abe, who was Japan’s longest-serving prime minister. https://t.co/p6Ux2TPe3w

— The Associated Press (@AP) September 16, 2020

Yoshihide Suga has been elected as the new head of Japan’s ruling party, virtually guaranteeing him parliamentary election as the country’s next prime minister. https://t.co/Qjb7UPKAPp

— The Associated Press (@AP) September 14, 2020

Japanese prime minister hopeful Yoshihide Suga says he lacks the kind of diplomatic skills that outgoing leader Shinzo Abe has, including Abe's personal friendship with President Trump, and that he will need his assistance if he assumes the top job. https://t.co/Z176gjbjIN

— The Associated Press (@AP) September 12, 2020

https://twitter.com/AFP/status/1306237603637874688

#UPDATES Japan's parliament elects Yoshihide Suga prime minister, with the former chief cabinet secretary expected to stick closely to policies championed by Shinzo Abe during his record-breaking tenure https://t.co/BsfvhxSd6V pic.twitter.com/YXORmDXKA9

— AFP news agency (@AFP) September 16, 2020

Japan's parliament votes today for the country's next prime minister, with powerful cabinet secretary Yoshihide Suga all but assured the top jobhttps://t.co/8wZhfDupzw pic.twitter.com/ULPxi84Riw

— AFP news agency (@AFP) September 16, 2020

VIDEO: Japan's chief cabinet secretary Yoshihide Suga pledges a continuation of Shinzo Abe's policies as he is elected as the ruling party's new leader, making him all but certain to become the country's next prime minister pic.twitter.com/Utn5ZAoruf

— AFP news agency (@AFP) September 15, 2020

VIDEO: Japan ruling party elects Yoshihide Suga as PM successor.

The vote makes Suga all but certain to replace Shinzo Abe as the country's next prime minister pic.twitter.com/l9dfDW0Wee

— AFP news agency (@AFP) September 14, 2020

Japan's ruling party votes today for its next leader, with top government adviser Yoshihide Suga all but certain to win and replace Shinzo Abe as the country's new prime ministerhttps://t.co/yXRA6YPdmV pic.twitter.com/wRzMpvdWNV

— AFP news agency (@AFP) September 14, 2020

Japan's Yoshihide Suga to formally take up PM job, announce 'continuity' cabinet https://t.co/lCq86q9598 pic.twitter.com/8TVMcOF1tS

— FRANCE 24 (@FRANCE24) September 16, 2020

Japan's Yoshihide Suga wins leadership race to succeed outgoing PM Shinzo Abe https://t.co/XJCoFr5ful pic.twitter.com/wS6Dbftjiu

— FRANCE 24 (@FRANCE24) September 14, 2020

https://twitter.com/France24_fr/status/1305432334355902464
https://twitter.com/France24_en/status/1305441224132898817
https://twitter.com/i_montaigneEN/status/1305157795155714049

Concerns about the US’ readiness and ability to fulfill its security commitments have led Japan to enact security reforms to enhance its value as an ally while moving toward a more autonomous defense posture to prepare for the worst-case scenario.

➡️ https://t.co/CPn7pN2wRD pic.twitter.com/9aIPHUl32E

— IFRI (@IFRI_) July 24, 2020

In Japan, language is an integral part of a vertical society in which submission is a virtue. Japanese has different words for addressing a superior, a colleague or a sibling, which signal their place in society.https://t.co/1huvL32KBl

— Le Monde diplomatique in English (@LMdiplo) September 13, 2020

Years after the tsunami that swept northeast Japan, towns are being rebuilt. But will their inhabitants return, and should they? Fukushima’s toxic legacy will last for decades.

(September: the longer view.)https://t.co/MD2pzQ0djt

— Le Monde diplomatique in English (@LMdiplo) September 13, 2020

Yoshihide Suga won Japan's ruling party leadership race, virtually guaranteed to become the country's next prime minister. https://t.co/XLmF1dJ6ss

— DW News (@dwnews) September 14, 2020

Recent articles about Japan (mainly on new cabinet) 主に新内閣発足についての日本関連英文記事 Vol.1

All the below tweets are in English.

日本関連ツイートを拾うことは通常どおり特にしない予定でしたが、Reuters社を中心に以前よりは数が増えている感触があるので、前回投稿分以降の日付のものを中心にざぁっとですが拾ってみました。３回に分けて投稿します。
While I have not intended to collect news articles mainly on Japan’s new cabinet, I have come to confirm that there are more articles – mainly by Reuters – related to such issues than before as I have thought. That is why I collected roughly and posted here mainly tweets after the last post (Sep 8). This is the first of the three posts this time.

Hitachi to pull plug on north Wales nuclear power station https://t.co/9UiBT8ivbX

— The Guardian (@guardian) September 15, 2020

A Japan trade deal is little consolation if Britain is locked out of the EU https://t.co/VFXzXABLgg

— The Guardian (@guardian) September 13, 2020

Japan trade deal is small beer – but a welcome distraction https://t.co/PYes0nZkXr

— The Guardian (@guardian) September 11, 2020

UK government hails 'historic' trade deal with Japan https://t.co/tCu1vE1VHZ

— The Guardian (@guardian) September 11, 2020

Tokyo Olympics must be held at 'any cost', says Japanese minister https://t.co/s3iKj7upPC

— The Guardian (@guardian) September 8, 2020

Yoshihide Suga emerging as favourite to become Japan's prime minister https://t.co/kvdxwSftOD

— The Guardian (@guardian) September 1, 2020

#FPCJ #japannews @guardian
Yoshihide Suga to be Japan's prime minister after winning party vote https://t.co/NvynYefFBG

— Foreign Press Center Japan/フォーリン・プレスセンター (@fpcjpn) September 15, 2020

#FPCJ #japannews @guardian
Yoshihide Suga: the farmer's son set to be Japan's next PM https://t.co/LNojbwYdMz

— Foreign Press Center Japan/フォーリン・プレスセンター (@fpcjpn) September 14, 2020

Yoshihide Suga was elected Japan’s new prime minister in a parliamentary vote, following the resignation of Shinzo Abe https://t.co/3topdlCjap

— The Telegraph (@Telegraph) September 16, 2020

Who is Yoshihide Suga, the new Prime Minister of Japan? https://t.co/s885naHuXp

— The Independent (@Independent) September 16, 2020

Yoshihide Suga formally elected as Japan’s new prime minister https://t.co/3JhhviQCOW

— The Independent (@Independent) September 16, 2020

Yoshihide Suga: The unexpected rise of Japan’s new prime minister https://t.co/VbOcBegU78

— BBC News (World) (@BBCWorld) September 16, 2020

Yoshihide Suga elected Japan's new prime minster succeeding Shinzo Abe https://t.co/ifNL6ETIOn

— BBC News (World) (@BBCWorld) September 16, 2020

Yoshihide Suga: The strawberry farmer's son on track to be Japan's PM https://t.co/QrvbOikYnt

— BBC News (World) (@BBCWorld) September 14, 2020

#FPCJ #japannews @BBCWorld
BBC News – Yoshihide Suga: The strawberry farmer's son on track to be Japan's PM https://t.co/t8t07LBXBr

— Foreign Press Center Japan/フォーリン・プレスセンター (@fpcjpn) September 15, 2020

Japan's new prime minister Yoshihide Suga promises to turn round economy after succeeding Shinzo Abe https://t.co/GR4b8Dk1tf

— SkyNews (@SkyNews) September 16, 2020

Yoshihide Suga is set to become Japan's new prime minister, following the resignation of Shinzo Abe https://t.co/iWjgw5zvB7

— SkyNews (@SkyNews) September 14, 2020

Each year, the Japanese drink enough ready-to-drink coffee to fill Tokyo’s new Olympic Stadium almost to the brim https://t.co/rz81kHc1J0

— The Economist (@TheEconomist) September 16, 2020

Japan's shrinking and ageing population is stoking the demise of rural railway lines https://t.co/pXlPOztwDu

— The Economist (@TheEconomist) September 16, 2020

Suga Yoshihide secured the support of Japan’s ruling Liberal Democratic Party by pledging continuity and stability at a time of crisis https://t.co/pPcvZVPBXe

— The Economist (@TheEconomist) September 15, 2020

Today on “The Intelligence”: Japan’s new prime minister, the state of the World Health Organisation and the great canine schism among Egypt’s clerics https://t.co/xDPKcE3gSE

— The Economist (@TheEconomist) September 15, 2020

If Japan's next prime minister succeeds, it will be thanks in large part to the groundwork laid by Abe Shinzo https://t.co/SALMLrrYPp

— The Economist (@TheEconomist) September 6, 2020

Many have cast Abe Shinzo's resignation as an admission of defeat. But Japan's outgoing prime minister has done a far better job than is commonly acknowledged. Our cover in Asia this week https://t.co/epAEDInipU pic.twitter.com/PnzNEhbBHR

— The Economist (@TheEconomist) September 3, 2020

“It says: ‘Please attack us’,” complains a campaigner against a proposed military base in Japan https://t.co/abFed4jNNm

— The Economist (@TheEconomist) August 15, 2020

#lockdown giving you itchy feet? Over on our #blog, Dr Sonia Favi discusses how in the Tokugawa era, #maps provided a 'virtual' means of exploring and domesticating the Japanese territory, even when physical travel wasn’t possible https://t.co/5Aw3iZidtC @TheJohnRylands @UoMSALC pic.twitter.com/VMnnLZANu8

— JRRI (@JRRIManchester) July 6, 2020

Yoshihide Suga is not your typical Japanese politician and yet the 71-year-old son of a strawberry farmer is about to become Japan's next prime minister | @ErykBagshaw https://t.co/YdxLk4wGgn

— The Sydney Morning Herald (@smh) September 14, 2020

Shinzo Abe's chief cabinet secretary Yoshihide Suga is set to become Japan's next prime minister after winning a mandate to continue his predecessor's domestic and foreign policy | @ErykBagshaw https://t.co/L5ehz7jTpb

— The Sydney Morning Herald (@smh) September 14, 2020

Yoshihide Suga, Japan's Chief Cabinet Secretary and a longtime loyal assistant of outgoing Prime Minister Shinzo Abe, has emerged as a favourite to succeed him in an upcoming internal party vote https://t.co/n1zNdzRRgy

— The Sydney Morning Herald (@smh) September 2, 2020

David Walton and Akimoto Daisuke: The decision by the Turnbull government in 2016 to select a French company to produce Australia’s next generation of submarines over Japan’s tender highlighted the limitations of networks and friendships.https://t.co/HRpQaOGhts

— The Lowy Institute (@LowyInstitute) September 4, 2020

"With Australia seeking ever-closer regional cooperation with Japan these days, it will be interesting to see whether the country’s investors will be unnerved by being caught in Australia’s trade row with China."@Greg__Earl writes for The Interpreter.https://t.co/NWqOT8rfcL

— The Lowy Institute (@LowyInstitute) August 31, 2020

Abe aimed to move mountains, setting Japan high goals for the future | Purnendra Jain https://t.co/vynrzxabC2

— The Lowy Institute (@LowyInstitute) August 30, 2020

With the Indo-Pacific increasingly a battleground for technological competition, it appears likely that US-China tensions will complicate Japan-ASEAN digital ties.

Elliot Silverberg and Patrick Madaj write for The Interpreter.https://t.co/lKvF8wR7P4

— The Lowy Institute (@LowyInstitute) August 16, 2020

"In a similar address to the Lowy Institute a year ago, @ScottMorrisonMP also praised India and Japan as countries with 'shared values' to Australia."@ConversationEDU https://t.co/iARwXSrBzA

— The Lowy Institute (@LowyInstitute) August 6, 2020

"In a commentary last year written for The Interpreter blog from Australia's Lowy Institute, Layton detailed just how far the Chinese flights stretch the JASDF, and how China has the resources to push Japan to limits it may not be able to reach."@cnni https://t.co/LnI3HSyOxu

— The Lowy Institute (@LowyInstitute) July 30, 2020

"An overwhelming 82 per cent of Australians said they expected Japan to act responsibly in the world. On the same question, the response regarding China was a dismal 23 per cent"

Nonresident Fellow @Rory_Medcalf on Lowy Institute Poll in @FinancialReview https://t.co/0dAWDLfKCd

— The Lowy Institute (@LowyInstitute) July 13, 2020

Beyond Covid, the chance for a broader Australia-Japan relationship | Donna Weeks https://t.co/jWd4qbeuwC

— The Lowy Institute (@LowyInstitute) July 6, 2020

As China rises, does Australia, India, Japan, and the United States have any real prospect of rebalancing relationships in Asia?

Read the latest Lowy Institute Analysis on the Security Quadrilateral Dialogue by Dr Lavina Lee. https://t.co/3rHK0bjip3

— The Lowy Institute (@LowyInstitute) May 22, 2020

Japan: Article 9 conundrum rears its head again | David Walton https://t.co/g3erhFcktW

— The Lowy Institute (@LowyInstitute) February 24, 2020

Japan–South Korea tensions show little sign of easing | Kate Kalinova https://t.co/a5lWZFyghy

— The Lowy Institute (@LowyInstitute) February 17, 2020

#BREAKING Japanese Coastguard has reportedly made the decision to suspend its fulltime search for the 40 people still missing from the livestock ship. https://t.co/5kPFsNszQP pic.twitter.com/v3KPgjWKNA

— nzherald (@nzherald) September 10, 2020

#BREAKING Missing Kiwis: Japan to resume search for crew of livestock ship https://t.co/tAqQjJTgcc pic.twitter.com/YtKCeBkt2z

— nzherald (@nzherald) September 7, 2020

#BREAKING The second person rescued by Japanese coastguard has died. https://t.co/YrzrVGD9Sg pic.twitter.com/G3vTOgyyKc

— nzherald (@nzherald) September 4, 2020

#BREAKING They sent a distress signal at 4.45am NZT off the coast of Japan as the area was hit by a Typhoon. Now the ship has disappeared. https://t.co/UJUmRTrPFY pic.twitter.com/KGDrbXTWTJ

— nzherald (@nzherald) September 2, 2020

Japan's Parliament has elected Yoshihide Suga as prime minister, replacing long-serving leader Shinzo Abe with his right-hand man. https://t.co/i4yQL9llz4

— CBC News (@CBCNews) September 16, 2020

Yoshihide Suga has been elected as the new head of Japan's ruling party, virtually guaranteeing that he will become the country's next prime minister. https://t.co/rqR2DwTZGn

— CBC News (@CBCNews) September 14, 2020

One person in Japan is dead, and at least two are missing in South Korea after a powerful typhoon. https://t.co/f8sxEEjNOw

— CBC News (@CBCNews) September 8, 2020

U.S. authorities have arrested a former Green Beret and his son who are accused of using large boxes to help scurry Nissan chairman Carlos Ghosn out of Japan. https://t.co/UPxjNx3A05

— CBC News (@CBCNews) May 20, 2020

As the coronavirus spreads in Japan, the chief executive of the Tokyo Games said Friday he can't guarantee the postponed Olympics will be staged next year — even with the long delay. https://t.co/V6QqzigJwC

— CBC News (@CBCNews) April 10, 2020

Japan's prime minister says he will declare a state of emergency for seven prefectures, with Japan also launching its largest ever stimulus package. https://t.co/f6SWfrhyQg

— CBC News (@CBCNews) April 7, 2020

The streets of Tokyo remain busy as Japan adopts its own approach to preventing the spread of coronavirus, one that relies on tracing cases and requesting cooperation, not lockdowns. https://t.co/YKNNsYkV4N @sasapetricic

— CBC News (@CBCNews) April 4, 2020

Japan Olympic minister Seiko Hashimoto says the Tokyo Summer Games could be held later in 2020 due to fast-spreading COVID-19. https://t.co/8gEqMSG8cX

— CBC News (@CBCNews) March 3, 2020

Canadian quarantined in Japan with asymptomatic COVID-19 describes comforts during enforced stay. https://t.co/HfOuAh3Jhb pic.twitter.com/y70dRyVzIE

— CBC News (@CBCNews) February 27, 2020

Japan’s Yoshihide Suga poised to win party race, succeed Shinzo Abe as PM https://t.co/XHP4temuFe

— The Globe and Mail (@globeandmail) September 14, 2020

Japan, eyeing Olympics, lines up half-billion doses of COVID-19 vaccine https://t.co/N3ShUXL25O

— The Globe and Mail (@globeandmail) August 28, 2020

Japan says China has used coronavirus to expand territory, influence https://t.co/6vtuc3NY8T

— The Globe and Mail (@globeandmail) July 14, 2020

Japan to end Tokyo’s state of emergency, eyes massive new stimulus https://t.co/2xqo1lBlOs pic.twitter.com/SQsnCVxqFx

— The Globe and Mail (@globeandmail) May 25, 2020

Japan’s Shinzo Abe slammed over ‘stay home’ shutdown tweet https://t.co/ZpaFBQxGOg pic.twitter.com/93TI0ssMk1

— The Globe and Mail (@globeandmail) April 13, 2020

Nearly 40 feared dead as torrential rains continue to ravage southwest Japan https://t.co/6f7TjQpdH8 pic.twitter.com/DRfb2d0pvW

— The Globe and Mail (@globeandmail) July 6, 2020

Japan bracing for dangerously powerful Typhoon Haishen https://t.co/6iorZ3r31N

— The Globe and Mail (@globeandmail) September 4, 2020

Japan’s ruling party urges government to cancel Xi’s visit over new Hong Kong national security law https://t.co/CVKC12xKeB pic.twitter.com/g0Ybpfpp4g

— The Globe and Mail (@globeandmail) July 7, 2020

Japan ignored the usual rules but contained COVID-19. How did it work? https://t.co/dDDSjdHmbe

— National Post (@nationalpost) May 25, 2020

#Breaking: Olympic Games delayed one year after agreement reached with IOC and Japan PM. https://t.co/5AIrozWunM

— Toronto Star (@TorontoStar) March 24, 2020

Articles about Japan after Prime Minister’s resignation announcement through today 首相辞意表明後今日までの日本関連英文記事

All the below tweets are in English.

標記につき取り急ぎ貼っておきます。

Japan's Suga says coronavirus a top priority, to stay on Abe policy course https://t.co/KH014DRWAv pic.twitter.com/4qduiKwGMc

— Reuters (@Reuters) September 8, 2020

Japan to spend $6.3 billion from emergency reserve for coronavirus vaccines https://t.co/FQOL8jfScS pic.twitter.com/d0szcvoMhm

— Reuters (@Reuters) September 8, 2020

Japan's Suga signals chance of calling snap election: Asahi https://t.co/FNnJVT5bRf pic.twitter.com/HysayXM3Fx

— Reuters (@Reuters) September 8, 2020

Senior Japan ruling party member suggests early election: media https://t.co/VWOXatSa1Q pic.twitter.com/c2pMrevZLd

— Reuters (@Reuters) September 6, 2020

Japan's Suga jumps in popularity, tops favourability poll for next PM https://t.co/GrPwSAlYxI pic.twitter.com/qpyQBhiAhV

— Reuters (@Reuters) September 4, 2020

Backroom deals, old-school politics help rise of Japan's likely new premier https://t.co/vmEpeiK4uo pic.twitter.com/kgPBXJYtJZ

— Reuters (@Reuters) September 3, 2020

Japan defence chief Kono expects to be prime minister one day, but backs Suga to succeed Abe https://t.co/DD2zcP0akQ pic.twitter.com/UtWRxXKs1T

— Reuters (@Reuters) September 3, 2020

Japan’s Chief Cabinet Secretary Yoshihide Suga has officially declared he will run for the leadership of the ruling party, making him the top contender to take over from Prime Minister Shinzo Abe https://t.co/TzpKpHbjBC pic.twitter.com/jORgubKuHm

— Reuters (@Reuters) September 3, 2020

Factbox: A stern enforcer who does 100 sit-ups daily – some facts about Japan's Suga https://t.co/pcTXr9DwNM pic.twitter.com/jEb9W3UV5k

— Reuters (@Reuters) September 3, 2020

UK/Japan trade deal good for consumers, companies, Johnson tells Abe https://t.co/TNjnqVIUQH pic.twitter.com/WXRIUdjXun

— Reuters (@Reuters) September 2, 2020

Japan's Suga says to brief on party leadership race, in signal he intends to run https://t.co/6WRex12uln pic.twitter.com/5bClAPgbrY

— Reuters (@Reuters) September 2, 2020

Suga as Japan's next premier may be tough partner for Bank of Japan https://t.co/sdxZ95GQMq pic.twitter.com/Gqtqh5tZnj

— Reuters (@Reuters) September 2, 2020

Japan's Suga expected to announce candidacy for PM race https://t.co/73AeSksV6K pic.twitter.com/krK0Mmsae7

— Reuters (@Reuters) September 2, 2020

Yoshihide Suga, a long-time lieutenant of outgoing Japanese Prime Minister Shinzo Abe is seen as a top contender in the PM race after he won the backing of the ruling party's largest faction https://t.co/Hgl9w7shZi pic.twitter.com/eyRQRDo5Jx

— Reuters (@Reuters) September 1, 2020

Japan's next premier to find pandemic eroding job market gains made by 'Abenomics' https://t.co/0L8X5in763 pic.twitter.com/gNn0nIHzzi

— Reuters (@Reuters) September 1, 2020

Suga seen top contender in Japan PM race as ruling party plans slimmed-down vote https://t.co/wVg1hKtAud pic.twitter.com/IXQ4q2lUwz

— Reuters (@Reuters) September 1, 2020

Japan former foreign minister Kishida announces candidacy to succeed PM Abe https://t.co/KAJ37IIfMb pic.twitter.com/qMr56YBcHi

— Reuters (@Reuters) September 1, 2020

Japan's Motegi: to decide whether to run in party leadership race in a day https://t.co/8lZGGf2BoK pic.twitter.com/o5VXzZLFuc

— Reuters (@Reuters) September 1, 2020

Yoshihide Suga, Japan’s chief cabinet secretary and a long-time lieutenant of outgoing Prime Minister Shinzo Abe, won the backing of the largest faction of the ruling party to become its next leader, according to public broadcaster NHK https://t.co/CLTrfpHfLq pic.twitter.com/vwmsuBxYPr

— Reuters (@Reuters) September 1, 2020

Japan LDP execs agree on simplified format to pick next PM: Nikai https://t.co/JBSiprHkGl pic.twitter.com/MKUrzwGUYf

— Reuters (@Reuters) September 1, 2020

Japan Defence Minister Kono says still undecided on run for ruling party leadership https://t.co/RIOCsS4eR8 pic.twitter.com/mL7SYNzqWs

— Reuters (@Reuters) September 1, 2020

Ex-Japan defence chief mum on whether he'll join PM race https://t.co/xL8Vv4OMDZ pic.twitter.com/UJZnho5erd

— Reuters (@Reuters) August 31, 2020

How does Abenomics stack up? Reuters asked the experts https://t.co/rk2GIdauOE pic.twitter.com/7uwEQXu575

— Reuters (@Reuters) August 31, 2020

Japan's ruling party to hold September 14 leadership vote; four possible candidates for PM https://t.co/vnOX7Hld4q pic.twitter.com/OyLahCgjeL

— Reuters (@Reuters) August 31, 2020

Japan's PM candidate Kishida cautious about cutting sales tax https://t.co/NX1GzOZzii pic.twitter.com/MF5DaqtiwV

— Reuters (@Reuters) August 31, 2020

Ex-defence minister Ishiba is people's choice for next Japan PM: polls https://t.co/vz2wwRC27L pic.twitter.com/FDUz78EpgK

— Reuters (@Reuters) August 31, 2020

In his first race for office, Japan's likely next prime minister knocked on 30,000 doors and wore out six pairs of shoes https://t.co/9u4C78fBxC

— The Wall Street Journal (@WSJ) September 7, 2020

By the time Prime Minister Shinzo Abe announced his resignation last week, he had presided over a remarkable and unexpected opening up of Japan to the world https://t.co/Q8QCHMDkLk

— The Wall Street Journal (@WSJ) September 3, 2020

Japan’s next leader will face a question many other countries are now grappling with because of the coronavirus pandemic: How much can central banks do to pull economies out of a deep malaise? https://t.co/ijydChWQXa

— The Wall Street Journal (@WSJ) August 31, 2020

Prime Minister Shinzo Abe’s two stints in office reshaped modern Japan https://t.co/VQbZJ35bZD

— The Wall Street Journal (@WSJ) August 29, 2020

Whoever Japan's Liberal Democratic Party elects as its leader, probably within the next week, will almost certainly become the country's next prime minister. But it isn’t clear who that will be. https://t.co/1vYWIME0Wb

— The New York Times (@nytimes) August 30, 2020

News Analysis: Whoever Japan's next leader is will have to face the coronavirus, a tanking economy, an aggressive China, a postponed Olympics and a U.S. election. And that's just the start. https://t.co/dHglv1aM1b

— The New York Times (@nytimes) August 30, 2020

Japan’s "Mr. Fixit," Yoshihide Suga, set to succeed Shinzo Abe as leader https://t.co/HaoZIM3NBs

— The Washington Post (@washingtonpost) September 1, 2020

Opinion: Shinzo Abe decided to go all out on Donald Trump. He’s probably regretting it now. https://t.co/u2VEjVoz9D

— The Washington Post (@washingtonpost) August 30, 2020

What does #Abe Shinzo’s resignation mean for Japan’s future? The post-Abe calculus is aggravated by Japan’s domestic political flux, a congested electoral calendar and unpromising economic and geopolitical environments, writes @RobertAlanWard | https://t.co/EelZfg6zG6 pic.twitter.com/5RHLVs3odh

— IISS News (@IISS_org) August 28, 2020

'The old paradigm of the US-Japan alliance is that Japan wears the "shield" and hosts the "sword". But that paradigm has been breaking down for many years,' says @graham_euan, Senior Fellow for Asia-Pacific Security | @firstpost https://t.co/56fnzqDI3B

— IISS News (@IISS_org) August 17, 2020

China’s rise as a geo-economic power has driven the Abe administration to reshape its foreign-policy bureaucracy and recalibrate its approach to economic statecraft – read more in the Strategic Comment | https://t.co/eVGsEQOXkB pic.twitter.com/3U0FLlthPA

— IISS News (@IISS_org) August 24, 2020

'Chinese activities in the waters around the Senkaku/Diaoyu islands have undergone a significant change over the past few months. This is a potentially dangerous development for Sino–Japanese relations.'
New Newsbrief from Dr Alessio Patalano.https://t.co/8ysPOtONLs pic.twitter.com/T0MwNK9M0h

— RUSI (@RUSI_org) August 22, 2020

🇫🇷 lost the 5th position to Japan in 2017 in the ranking of the Elcano #GlobalPresence Index, and now ranks 6th. However, in the European Presence Index, it keeps the 4th position after 🇩🇪, 🇬🇧 and 🇳🇱.
🔍 Explore results by @iolivie & @mgraciasn ⬇https://t.co/OZl9RJK3Zz

— Real Instituto Elcano (@rielcano) August 22, 2020

“China has a lot of cards to play, so the policies of the next administration—again, regardless of who is president—will have to respond to Beijing.”

Insights from @JJCarafano on the future of Asia policy via @jljzen: https://t.co/Pqn3BYeD0F

— Heritage Foundation (@Heritage) August 21, 2020

Yoshihide Suga, Japan's Chief Cabinet Secretary and a longtime loyal assistant of outgoing Prime Minister Shinzo Abe, has emerged as a favourite to succeed him in an upcoming internal party vote https://t.co/n1zNdzRRgy

— The Sydney Morning Herald (@smh) September 2, 2020

Japan's Prime Minister Shinzo Abe has been forced to resign due to ongoing poor health.https://t.co/OmmN6lmxpi

— nzherald (@nzherald) August 28, 2020

Five venerable Japanese companies were sitting in the bargain bin in plain sight. It took a 90-year-old Warren Buffett to scoop them up. https://t.co/LmocOAatM2

— The Wall Street Journal (@WSJ) September 5, 2020

Japanese conglomerate SoftBank fueled the recent stock market rally by buying options tied to billions of dollars worth of individual tech stocks, people familiar with the matter say https://t.co/5qJeeaemXS

— The Wall Street Journal (@WSJ) September 4, 2020

SoftBank value slumps as investors fear it may be the 'Nasdaq whale' https://t.co/TY75uJPCcI

— The Guardian (@guardian) September 7, 2020

Warren Buffett’s Berkshire Hathaway took stakes in five Japanese trading companies, expanding its reach abroad https://t.co/QJkPjn15ou pic.twitter.com/Dsc5vFQlUO

— Stuart Wallace (@StuartLWallace) August 31, 2020

BREAKING: Warren Buffett's Berkshire Hathaway buys stakes in Japan's five leading trading companies https://t.co/9RzX6prgmH

— CNBC Now (@CNBCnow) August 30, 2020

https://twitter.com/Forbes_MENA_/status/1300379518184689664

Berkshire Hathaway invests $6 billion in five Japanese companies https://t.co/GPzyETMsvI pic.twitter.com/JWGLP2GK5D

— New York Post (@nypost) August 31, 2020

The Japanese Coast Guard was searching for a livestock ship that capsized with dozens of crew members and nearly 6,000 cows aboard, after a typhoon barreled through East Asia on Thursday https://t.co/49zbjiV6Nx

— The New York Times (@nytimes) September 3, 2020

Japan's convenience store industry is under scrutiny after allegations that companies used strong-arm tactics to force franchisees to maintain 24-7 operations, leading overworked owners to collapse from exhaustion https://t.co/Jw6JgV5NZo

— The New York Times (@nytimes) September 3, 2020

Naomi Osaka brought seven face masks to the U.S. Open, each one honoring a victim of violence https://t.co/R8DtfLqODc

— The Washington Post (@washingtonpost) September 1, 2020

Japan coastguard finds second person in search for crew of capsized cattle ship https://t.co/jIvgQsXsbt

— The Guardian (@guardian) September 4, 2020

Typhoon Maysak: ship with 43 crew and nearly 6,000 cattle missing off Japan https://t.co/gU83kN9HXq

— The Guardian (@guardian) September 3, 2020

#BREAKING The second person rescued by Japanese coastguard has died. https://t.co/YrzrVGD9Sg pic.twitter.com/G3vTOgyyKc

— nzherald (@nzherald) September 4, 2020

Japan's Sumitomo sells all of its stake in U.S. Marcellus shale gas project https://t.co/LggosGUiNQ pic.twitter.com/CvYxUJ9YpS

— Reuters (@Reuters) September 8, 2020

Japan's economy sank deeper into its worst post-war contraction in the second quarter as the coronavirus jolted businesses, intensifying the challenge for the country's new leader https://t.co/eeC1TtV3Ku pic.twitter.com/72RDS5h49f

— Reuters (@Reuters) September 8, 2020

Japan real wages decline for fifth month in July as pandemic woes persist https://t.co/ujb8GDH0nK pic.twitter.com/TjeIxXD0hp

— Reuters (@Reuters) September 8, 2020

Japan's July household spending falls 7.6% year-on-year https://t.co/05HkfoDhDx pic.twitter.com/ncXaEsJqIB

— Reuters (@Reuters) September 8, 2020

Japan's Nishimura says rising income to underpin consumption https://t.co/5qJ2SSC5jr pic.twitter.com/1zwxo0quDi

— Reuters (@Reuters) September 8, 2020

Japan's second-quarter GDP revised down to annualised 28.1% contraction https://t.co/ciKbcDVRdG pic.twitter.com/sM3nX7nGwH

— Reuters (@Reuters) September 8, 2020

Japan real wages decline for fifth month in July as pandemic woes persist https://t.co/oLovkMNqCE pic.twitter.com/2mRvUgLL4R

— Reuters (@Reuters) September 8, 2020

Japan says it offered Mauritius 'unprecedented' support, including financial https://t.co/cDucu3Tijm pic.twitter.com/rcaUDTSeb5

— Reuters (@Reuters) September 7, 2020

Renault to develop, build next-generation Nissan Micra: report https://t.co/IIW1D4HZMe pic.twitter.com/w1AmP2J46G

— Reuters (@Reuters) September 7, 2020

The Fed’s landmark shift to a more tolerant stance on inflation will be a drag on the dollar for years and will raise hard questions about the role of central banking, challenging policymakers from Frankfurt to Tokyo https://t.co/PzzcVF2WEa pic.twitter.com/bwU58rbiqg

— Reuters (@Reuters) September 7, 2020

Japanese government exposed to 40% of $6.7 billion Nissan loans: sources https://t.co/s74k5ibgXO pic.twitter.com/3TL6RnDHc1

— Reuters (@Reuters) September 7, 2020

Death knell sounds for some of Japan's oldest department stores https://t.co/XkVMHEJQop pic.twitter.com/r2UTHa6EXI

— Reuters (@Reuters) September 7, 2020

Amazon Japan submits improvement plan to regulators: Asahi https://t.co/FchYZNr0i7 pic.twitter.com/lhstyjzaMm

— Reuters (@Reuters) September 4, 2020

Japan's government is considering further assistance to help Mauritius deal with a major oil spill after a Japanese-owned boat struck a coral reef pic.twitter.com/LELPYdmqgR

— Reuters (@Reuters) September 3, 2020

Japan's coastguard rescued one person while searching for a cargo ship carrying nearly 6,000 cattle and dozens of crew members that went missing in the East China Sea https://t.co/An8nLUfi4a pic.twitter.com/KZekO8cFJi

— Reuters (@Reuters) September 3, 2020

BOJ's Kataoka urges bolder easing to battle deflation risk https://t.co/2LxzPSU2SE pic.twitter.com/UWB9FJqFg5

— Reuters (@Reuters) September 3, 2020

Japan's August service sector activity worsens as pandemic stymies recovery https://t.co/wHHpqn8nBN pic.twitter.com/maiuZJwI0y

— Reuters (@Reuters) September 3, 2020

Japan looks to AI as coronavirus challenges go-and-see quality control mantra https://t.co/INQIGWyG16 pic.twitter.com/4oSruhvBft

— Reuters (@Reuters) August 31, 2020

As fintech upends banking, Japan regulator expects more cross-boundary tie-ups https://t.co/nhVjPT8MC3 pic.twitter.com/WlsEaJuhsB

— Reuters (@Reuters) August 31, 2020

Japan July retail sales fall 2.8% year-on-year, government data shows https://t.co/HlH0tdU2Sr pic.twitter.com/3bQ5tUxewH

— Reuters (@Reuters) August 31, 2020

From @Breakingviews: @johnsfoley explains why Warren Buffet is going big in Japan pic.twitter.com/tA2jBVqc13

— Reuters (@Reuters) September 1, 2020

Nippon Steel to seek overseas M&As, but not in Japan: president https://t.co/lKCoLkWAui pic.twitter.com/xgb2PQVlu1

— Reuters (@Reuters) September 1, 2020

Warren Buffett looks to Japan, takes 5% stakes in five biggest trading firms https://t.co/CErrl7nR2E pic.twitter.com/3wA9AUhtS8

— Reuters (@Reuters) August 31, 2020

Japanese PM Shinzo Abe says he's stepping down because of a chronic health problem https://t.co/0p5wm1yElD

— POLITICO (@politico) August 29, 2020

Japanese Prime Minister Shinzo Abe has expressed his intention to step down, citing his declining health, according to Japan’s NHK television and other media https://t.co/0p5wm1yElD

— POLITICO (@politico) August 28, 2020

Science and Technology 科学技術 Vol.9 ／ #Coronavirus #コロナウイルス Vol.11

All the below links and tweets are in English.

ツイッター検索で出て来た broadband と日本に関連するツイート（The below are broadband-related Tweets which happened to come out of Twitter search on Sep 6. They must be just a part of all the posted Tweets as usual.）

The HAPS #HAWK30 is a next generation #Solar powered #UAS >>> @aerovironment and @SoftBank via @globaliqx >>> #Broadband #UAV #Drones #IoT #5G #Robotics #defstar5 #Aerospace >>> https://t.co/9dlZzzaKUz pic.twitter.com/qXF8hZ0cvU

— Mike Quindazzi ✨ (@MikeQuindazzi) December 19, 2019

City interview with Adrian Steckel, the boss of SoftBank-backed British satellite broadband firm OneWeb. He tells me the plans is to float in 24-36 months when it has launched all its satellites https://t.co/5bfuSmIj3c

— Jamie Nimmo (@JamieNimmo63) August 11, 2019

SoftBank is investing $125M in rural balloon broadband startup. pic.twitter.com/vMkawziQDX

— Digital Trends (@DigitalTrends) April 29, 2019

NTT Docomo’s bullet train mmWave 5G test speeds past 1Gbps https://t.co/LSWB46UTwp #Telecom #Networks #Telco #Cloud #Telecoms #Mobile #Wireless #IIoT #Broadband #IoT #EdgeComputing #5G @NTTDocomoNews @NTTDATAServices #japan

— Evan Kirstel #RemoteWork (@EvanKirstel) September 30, 2019

Docomo Offers 1Gbit/s Services to Train Going 283km/h Using 5G https://t.co/r2oDLyhnql via @Light_Reading #Telecom #Networks #Telco #Cloud #Telecoms #Mobile #Wireless #IIoT #Broadband #IoT #EdgeComputing #5G #japan @GlobalNTT @NTTDATAServices pic.twitter.com/DszjUnlXSP

— Evan Kirstel #RemoteWork (@EvanKirstel) October 1, 2019

Tokyo power company orchestrates 5G infrastructure sharing https://t.co/oJ1MCtD79Q #5G #APAC #BusinessModels #mmWave #Regulation #Research #SmartCities #Japan #Networks #Telecoms pic.twitter.com/bfdKQ9hQYT

— TelecomTV (@TelecomTV) March 19, 2019

KDDI is deploying https://t.co/TeRdCkxVRJ in Japan to tackle its huge MDU opportunity https://t.co/vxQywU8Ves #APAC #Broadband #Telecoms #Gfast #Fibre pic.twitter.com/WJnfp8FQYu

— TelecomTV (@TelecomTV) February 4, 2019

KDDI deploys Nokia gigabit https://t.co/vQJiRQTOpO solution to bring new services to its high-speed internet 'au Hikari' customers in Japan | Nokia https://t.co/RfBdVqtHiq #gfast #broadband

— Teresa Mastrangelo #broadband #smartcities (@broadbandtrends) February 4, 2019

KDDI takes conventional approach in land of new 5G architectures…https://t.co/34uaiPGsOM #wireless #5G #wifi #cellular #operators #spectrum #RAN #broadband #iot #rethinktechnology #iot @KDDI_Research @NTTDocomoNews @Rakuten @SoftBank @ericsson @nokia pic.twitter.com/cMpl3iWGNs

— Wireless Watch (@RethinkWireless) October 9, 2019

Gfast Brings High-Speed Broadband to KDDI MDU Customers https://t.co/S6XWP92djM

— Broadband World News (@BroadbandWN) February 5, 2019

BBWN Bites: Verizon, Spectrum Top Netflix Tier-One Speed Rankings
Also today, Boris's broadband goal gets no love in Parliament, Roku delivers for Apple fans, Tubi targets UK and kids, Rakuten TV brings freebie ad-supported service, Chile seeks tenders forhttps://t.co/UgMkqUnWTV

— Broadband World News (@BroadbandWN) October 15, 2019

Network disaggregation saves Rakuten up to 60% on their new 5G network – we've seen the same on fixed broadband networks. Time to goodbye to monolithic network hardware?#networkdisaggregation https://t.co/A7YpZPAfqA

— RtBrick (@rtbricknet) August 26, 2020

On this episode of Quick Talk, a TM Forum podcast, we discuss Rakuten Mobile’s #5G deployment delay due to #COVID-19, the impact of US-China relations on @Huawei and taking mobile broadband pricing for granted. Listen now: https://t.co/v26HjWItYF cc: @Rakuten_Mobile

— TM Forum (@tmforumorg) May 28, 2020

Rakuten invests in "AST & Science" space venture to extend future mobile coverage to people and devices across the planet, with the first mobile broadband network that will be broadcast from space.https://t.co/MnD4QDPFlC

— Rakuten Today (@RakutenToday) March 5, 2020

AST & Science raises $110M Series B led by Rakuten and Vodafone to build a broadband network via a constellation of satellites that link directly to smartphones (@chenry_sn / SpaceNews)https://t.co/76BiThEvto https://t.co/IQqsJFzkPi

— Techmeme (@Techmeme) March 8, 2020

Rakuten and Vodafone are the lead investors in a just-announced space-based cellular broadband network called SpaceMobile from AST & Science. https://t.co/4eLDMCPcWd

— Via Satellite (@Via_Satellite) March 4, 2020

We are proud to partner with Rakuten to demonstrate #5G's capabilities for enhanced mobile broadband and industry 4.0 applications: https://t.co/AXXCWwLUBV pic.twitter.com/peFzI18vCI

— Nokia for CSPs (@nokianetworks) October 2, 2018

BBWN Bites: Verizon, Spectrum Top Netflix Tier-One Speed Rankings
Also today, Boris's broadband goal gets no love in Parliament, Roku delivers for Apple fans, Tubi targets UK and kids, Rakuten TV brings freebie ad-supported service, Chile seeks tenders forhttps://t.co/ULUbf2u66W

— Broadband World Forum (@BBWorldForum) October 15, 2019

Gfast Brings High-Speed Broadband to KDDI MDU Customers
Japanese provider KDDI will use Nokia's Gfast solution to bring speeds of up to 830 Mbit/s to city dwellers.https://t.co/Dw1zkJ7Pbq

— Broadband World Forum (@BBWorldForum) February 5, 2019

KDDI and Nokia boost Japanese broadband speeds by 800% https://t.co/DBrYmtCE8e pic.twitter.com/4JZsUnlAXf

— Connected Britain (@ConnBritain) February 4, 2019

For example – here is Masa talking about putting off short-term profits to gain long-term market share. Which he did in the Japanese broadband market in the early 2000s and the Japanese wireless market in the late 2000s.https://t.co/NRanIGHnc9

— Masa Capital (@MasaSonCap) June 9, 2020

Merger delays and teething troubles pull back Sprint and TMO 5G roll-outs…https://t.co/vzN3F8wZZ9 #wireless #5G #wifi #cellular #operators #spectrum #RAN #broadband #rethinktechnology @sprint @TMobile @Rakuten @ATT @verizon pic.twitter.com/YswQgCkWcF

— Wireless Watch (@RethinkWireless) September 3, 2019

https://twitter.com/dinoflore/status/1100105372709343234

Nokia and KDDI trial 5G with AirScale radio for wireless ultra-broadband in megacities https://t.co/2CG7axmiFv pic.twitter.com/SrxN7i5DiH

— Nokia News (@nokianews) May 12, 2017

Canada’s telecom watchdog to work with Japan to combat spamhttps://t.co/SUVLncU8zJ pic.twitter.com/vGGfayxUV0

— MobileSyrup (@MobileSyrup) January 6, 2018

.@SoftBank held talks with @BSNLCorporate for leasing out broadband bandwidth from #OneWeb's low earth orbit communication satellites to disrupt the telecom tech landscape in India with low latency Internet and voice services https://t.co/lRPEVPV2eP

— Economic Times (@EconomicTimes) April 27, 2018

SoftBank has agreed to invest around $500 million more in satellite broadband provider OneWebhttps://t.co/T2689aGNIU

— The Wall Street Journal (@WSJ) December 12, 2017

KDDI's broadband deal seeks clout with households https://t.co/OOnmpD8isg pic.twitter.com/DyhYiMtgBI

— Nikkei Asian Review (@NAR) December 8, 2016

Softbank/Sprint CEO Masa Son uses Comcast, and isn't happy with his broadband speeds. #codecon pic.twitter.com/dphPmctFoX

— Brad Molen (@phonewisdom) May 28, 2014

.@SoftBank is unlikely to keep supporting @OneWeb, a source familiar with the situation said, as an activist investor agitates for change at the Japanese internet giant amid rumours that its LEO broadband holding is mulling bankruptcy. https://t.co/CLIYbv9FiY pic.twitter.com/IF1ELWmx9c

— Connectivity Business (@connectivity_b) March 26, 2020

Japan's fussy food shoppers finally go online amid pandemic | The Japan Times. The notable thing here is the comment from a Japanese journalist that Britain is the odd man out with broadband. Even on Japanese islands you get broadband! https://t.co/2pGdBXam0Y

— Maurice is not a nice man (@colonelmuppet) July 5, 2020

Half of UK consumers struggled with broadband speeds — NTT DATA @informationage #data #analytics https://t.co/bOf3GLGplT

— Eric Axelrod (@axelrod_eric) August 29, 2020

Only 8-10% of premises in the UK are connected to full-fibre broadband. It's 97% in Japan.

8 in 10 of us experienced internet problems in the last year.

So we'll make the very fastest full-fibre broadband free to everybody, in every home in our country.

That's real change.

— Jeremy Corbyn (@jeremycorbyn) November 14, 2019

Why do we need action on Broadband? Try this. The UK has low levels of full-fibre broadband internet, at just 7%. In comparison, Portugal has 89%, Japan 97% and South Korea 99%. Now do you see why existing solutions can’t work? If they could have they already would have.

— Richard Murphy (@RichardJMurphy) November 15, 2019

Like Lab has said *so* many times, 95% of people won't have their taxes raised

UK has one of the worst rates of broadband- 7%. Portugal 89%, Japan 97% & S. Korea 99% #freebroadband would boost productivity by £59bill, bring 1/2mill ppl into the work & boost rural economies https://t.co/u5Nwq9rp2O

— antonia jennings (@tweetingantonia) November 15, 2019

Actual Wow!

The BBC describe Labour's plan to hook everyone up to Broadband (like Japan & South Korea do) as Communism

This really is a new level of bias by the BBC – even for their standards. pic.twitter.com/VRCxdCJbx6

— The Pileus #RefugeesWelcome (@thepileus) November 15, 2019

when I was in rural Japan in 2005, I could get 150mbps broadband because the government had built it. In 2019 my parents in rural Suffolk can only get 4mpbs broadband because private enterprise has failed to build it.

— Jonathan Paige (@johnnypaige) November 14, 2019

Average monthly cost of broadband:

Russia: $10
Poland $18
France: $31
Mexico: $33
Germany: $37
Japan: $37
Britain: $40
China: $41
Chile: $46
Denmark: $51
Australia: $53
Sweden: $56
Canada: $58
.
.
.
United States: $68

This is why monopolies are bad. https://t.co/3zJ7RDrau9

— Public Citizen (@Public_Citizen) November 11, 2019

Even our internet is neo-Liberal…

Aust is coming last in affordability rankings for entry-level broadband services.

Of developed (OECD) nations, Aust is at 36th. Japan is first, US 6th, UK 7th, New Zealand 21st ⁦@QuentinDempster⁩ #auspol #nbn https://t.co/yGouPHfeCS

— Denise Shrivell – North Sydney for an Independent (@deniseshrivell) August 27, 2019

Holy shit, New Zealand is ahead of Japan in Speedtest's fixed broadband speed global index https://t.co/2ec6JHO38L pic.twitter.com/YZoFeXuv4E

— Andrew Sykes (@Interlime) September 15, 2018

By the end of 2022, China, Japan, South Korea, Canada and the U.K. will have nearly 2X the amount of mid-band spectrum as the U.S. Our latest report outlines near-term opportunities for the U.S. to close the mid-band spectrum deficit: https://t.co/oiOx1zaXBJ pic.twitter.com/wkk4YR2Qd0

— CTIA (@CTIA) July 11, 2020

Military Cyber Affairs reports Chinese government used China Telecom to divert Internet traffic between 2015 and 2017. The report named 4 specific routes: Canada to South Korea, US to Italy, Scandinavia to Japan, and Italy to Thailand. https://t.co/v0EGoV4YkQ pic.twitter.com/pEMmfAGoGZ

— Laurent Perche (@Laurent_Perche) November 9, 2018

Canada can learn from initiatives in Japan & Australia on broadband use & adoption: https://t.co/5LCZx89zPs #DPSummit17 pic.twitter.com/zUPPjjuGPe

— Canadian Chamber of Commerce (@CdnChamberofCom) February 15, 2017

"5G war" as distraction from universal fiber to the prem #FTTP: "I’ve been hearing about the 5G war for a few years now and I still don’t know what it means…If there is now a 5G war, then why hasn’t there been a fiber-to-the-home war?" https://t.co/uV7MxFSZuh

— U.S. Telecom Infrastructure Crisis (@EldoTelecom) December 27, 2019

After US, Japan, Austalia now its time for Germany to stop Huawei from getting into their critical telecom infrastructure. It is really needed #5G #IoTSecurity https://t.co/Xp4Fx1pB0g

— Contra (@BannaGordhan) November 15, 2018

The British government decided to remove Huawei equipment from its 5G networks by the end of 2027. Two days later, they ask Japan to help build its 5G infrastructures. More on #InsideTelecom.#telecom #tech #5g #Britain #uk #japan #network https://t.co/Gi2yJfJXmo

— InsideTelecom (@insidetelecom_) July 27, 2020

Spot on from @TomTugendhat. “Every general wants to pick the battlefield and divide their enemy…Continuing to allow Huawei into the UK’s networks, triggering the reaction Washington has just ordered, that’s exactly what Beijing is succeeding in doing.” https://t.co/uXLgqs1YOX

— Owen Paterson (@OwenPaterson) May 6, 2020

The US is working with Australia & Japan to stop Chinese telecoms giant Huawei from building a major internet infrastructure project in #PNG. It's the latest sign of international efforts to curb China’s broadening influence in the Pacific
https://t.co/2mGJSQGqaH

— Keith Jackson AM (@PNGAttitude) September 28, 2018

The U.S. scrutiny has led governments in Australia, Britain, Canada, Germany, Poland and Japan to all examine their telecom supply chain, as well,while Australia and New Zealand have already restricted Huawei's potential involvement in their coming 5G net https://t.co/aXsGNktiVk

— jasonleeramsey (@jasonleeramsey) January 26, 2019

Ask the Japanese about FTTP #nbn whilst your there, you might learn something about not wasting $20 billion on a copper lemon #auspol #ausbiz #telecom #gennbn #broadband https://t.co/iwZ7O8jic8

— Mark A Gregory (@_markagregory) January 18, 2018